https://app.quri.ai/trials/NCT04052048/active-surveillance-snep-assay-registry-trial-for-prostate-c 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507838/safety-and-pharmacokinetics-study-of-multiple-ascending-dose 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508358/vaginal-sildenafil-for-primary-dysmenorrhea 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508241/a-study-to-learn-about-the-effect-of-study-medicine-called-p 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508020/a-research-study-looking-at-how-nnc0487-0111-affects-food-in 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508592/feasibility-study-of-the-seger-device-in-laparoscopic-gastro 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507903/obpm-panda2026-pivotal-evaluation-of-the-performance-and-saf 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT06368414/a-study-of-treatment-free-remission-in-chronic-phase-chronic 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507786/rapid-personalization-of-safety-plans-for-psychiatrically-ho 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07506863/a-study-to-investigate-the-efficacy-pharmacokinetics-and-saf 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507929/probiotic-for-weight-management-in-overweight-and-obese-adul 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507760/oral-decitabine-plus-ivosidenib-as-first-line-for-older-unfi 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508761/ipg7236-combined-with-toripalimab-in-participants-with-advan 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508748/a-study-on-the-effects-and-mechanisms-of-non-invasive-acupoi 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507955/probiotics-for-constipation-relief-in-adults 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507669/impact-of-metacalm-on-stress-of-healthy-people-with-acute-st 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507513/the-purpose-of-this-study-is-to-evaluate-the-efficacy-and-sa 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507422/post-market-evaluation-of-real-world-outcomes-and-durability 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508787/a-study-comparing-siplizumab-with-rabbit-anti-thymocyte-glob 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507253/pilot-study-on-the-correlation-between-accelerations-experie 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508839/evaluation-of-the-safety-and-efficacy-of-sali-10-probiotic-l 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507747/testing-an-adaptive-intervention-for-peer-supported-mobile-h 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07507812/fall-prevention-in-mci 2026-04-03T00:38:05.133Z weekly 0.7 https://app.quri.ai/trials/NCT07508007/impact-of-implementation-strategies-on-lp-a-testing-in-secon 2026-04-03T00:38:01.759Z weekly 0.7 https://app.quri.ai/trials/NCT07507266/emotions-from-salivary-biomarkers-in-an-architectural-contex 2026-04-03T00:38:01.552Z weekly 0.7 https://app.quri.ai/trials/NCT07508228/a-study-to-understand-how-a-study-medicine-called-pf-0732894 2026-04-03T00:38:01.337Z weekly 0.7 https://app.quri.ai/trials/NCT07501429/shockwave-for-elbow-and-wrist-spasticity-in-people-with-spin 2026-04-02T00:36:11.608Z weekly 0.7 https://app.quri.ai/trials/NCT07505082/nectero-east-system-retreatment-study 2026-04-03T00:34:17.581Z weekly 0.7 https://app.quri.ai/trials/NCT05828979/clinical-investigation-to-assess-a-new-artificial-urinary-sp 2026-04-03T00:34:09.714Z weekly 0.7 https://app.quri.ai/trials/NCT07505810/phase-trial-of-group-acyw135-meningococcal-conjugate-vaccine 2026-04-03T00:36:11.998Z weekly 0.7 https://app.quri.ai/trials/NCT07505823/phase-trial-of-group-acyw135-meningococcal-conjugate-vaccine 2026-04-03T00:36:36.202Z weekly 0.7 https://app.quri.ai/trials/NCT07505745/mots-c-for-improving-insulin-sensitivity-in-adults-with-pred 2026-04-03T00:35:52.245Z weekly 0.7 https://app.quri.ai/trials/NCT07505043/first-in-human-study-of-ish0688-safety-tolerability-pharmaco 2026-04-03T00:36:30.048Z weekly 0.7 https://app.quri.ai/trials/NCT07505004/double-blind-randomized-clinical-trial-evaluating-the-effica 2026-04-03T00:36:25.503Z weekly 0.7 https://app.quri.ai/trials/NCT07505030/to-evaluate-the-safety-tolerability-pharmacokinetics-pharmac 2026-04-03T00:36:26.559Z weekly 0.7 https://app.quri.ai/trials/NCT07505069/exploring-the-clinical-value-of-rt01-89zr-pet-imaging-in-sol 2026-04-03T00:36:36.863Z weekly 0.7 https://app.quri.ai/trials/NCT05061953/development-of-a-novel-functional-eye-tracking-software-appl 2026-04-03T00:34:38.703Z weekly 0.7 https://app.quri.ai/trials/NCT05041036/individual-patient-compassionate-use-of-nirogacestat 2026-04-03T00:36:23.364Z weekly 0.7 https://app.quri.ai/trials/NCT07505888/phase-trial-of-group-acyw135-meningococcal-conjugate-vaccine 2026-04-03T00:35:56.989Z weekly 0.7 https://app.quri.ai/trials/NCT07505303/mist-metabolic-intervention-with-semaglutide-and-thr-therapy 2026-04-03T00:36:10.794Z weekly 0.7 https://app.quri.ai/trials/NCT07504783/a-study-to-evaluate-the-real-world-experience-and-satisfacti 2026-04-03T00:36:06.859Z weekly 0.7 https://app.quri.ai/trials/NCT05547672/clinical-investigation-to-assess-a-new-artificial-urinary-sp 2026-04-03T00:35:52.877Z weekly 0.7 https://app.quri.ai/trials/NCT07505277/study-of-the-effects-of-food-formulations-containing-antioxi 2026-04-03T00:34:07.846Z weekly 0.7 https://app.quri.ai/trials/NCT07505771/a-phase-1-study-of-177lu-im-3050-in-participants-with-advanc 2026-04-03T00:34:21.891Z weekly 0.7 https://app.quri.ai/trials/NCT07505836/phase-trial-of-group-acyw135-meningococcal-conjugate-vaccine 2026-04-03T00:36:26.926Z weekly 0.7 https://app.quri.ai/trials/NCT07504263/phase-1-2a-study-of-rp-001-in-participants-with-advanced-mal 2026-04-03T00:37:59.802Z weekly 0.7 https://app.quri.ai/trials/NCT07503613/long-term-follow-up-study-of-aavanc80-antivegf-gene-therapy 2026-04-03T00:36:39.534Z weekly 0.7 https://app.quri.ai/trials/NCT07503171/hypoxia-and-hemodilution-testing-in-healthy-adult-volunteers 2026-04-03T00:37:12.478Z weekly 0.7 https://app.quri.ai/trials/NCT07503470/the-pre-poct-non-conveyance-trial-prehospital-point-of-care- 2026-04-03T00:37:40.071Z weekly 0.7 https://app.quri.ai/trials/NCT07503756/js212-combination-therapies-in-metastatic-colorectal-cancer 2026-04-03T00:36:57.650Z weekly 0.7 https://app.quri.ai/trials/NCT07503444/a-phase-3-study-of-fenfluramine-hydrochloride-in-rett-syndro 2026-04-03T00:37:55.551Z weekly 0.7 https://app.quri.ai/trials/NCT07502560/a-study-to-evaluate-the-effect-of-recombinant-zoster-vaccine 2026-04-03T00:37:26.361Z weekly 0.7 https://app.quri.ai/trials/NCT07502417/a-phase-1-study-to-assess-the-effect-of-abbv-722-on-ethinyl- 2026-04-03T00:36:51.367Z weekly 0.7 https://app.quri.ai/trials/NCT07502599/fainting-detection-and-early-warning-in-syncope-evaluation-s 2026-04-03T00:36:54.329Z weekly 0.7 https://app.quri.ai/trials/NCT07503028/an-exploratory-clinical-study-evaluating-allogeneic-ipsc-der 2026-04-03T00:37:36.956Z weekly 0.7 https://app.quri.ai/trials/NCT07504458/pivotal-open-label-phase-3-clinical-study-of-qtx-2101-in-adu 2026-04-03T00:37:25.601Z weekly 0.7 https://app.quri.ai/trials/NCT07503015/phase-1-study-of-hs-20152-in-healthy-participants 2026-04-03T00:37:40.595Z weekly 0.7 https://app.quri.ai/trials/NCT07503561/a-study-to-understand-how-a-new-unlicensed-drug-works-compar 2026-04-03T00:37:20.829Z weekly 0.7 https://app.quri.ai/trials/NCT07503808/a-study-of-ide034-in-adult-participants-with-locally-advance 2026-04-03T00:37:50.931Z weekly 0.7 https://app.quri.ai/trials/NCT07502508/phase-2-trial-of-icovamenib-in-participants-with-type-2-diab 2026-04-03T00:36:53.555Z weekly 0.7 https://app.quri.ai/trials/NCT07503769/chu-dual-energy-ablation-in-ventricular-arrhythmia 2026-04-03T00:36:42.248Z weekly 0.7 https://app.quri.ai/trials/NCT07502443/a-study-to-evaluate-the-efficacy-and-safety-of-alks-2680-in- 2026-04-03T00:37:58.691Z weekly 0.7 https://app.quri.ai/trials/NCT07502638/fxs6837-for-the-treatment-of-igan-patients 2026-04-03T00:37:22.736Z weekly 0.7 https://app.quri.ai/trials/NCT07503366/standardized-italian-network-enrolling-individuals-with-isle 2026-04-03T00:37:28.690Z weekly 0.7 https://app.quri.ai/trials/NCT07502495/phase-2-trial-of-icovamenib-in-participants-with-type-2-diab 2026-04-03T00:36:38.791Z weekly 0.7 https://app.quri.ai/trials/NCT07503886/an-exploratory-efficacy-and-safety-study-of-dfl24498-topical 2026-04-03T00:37:22.526Z weekly 0.7 https://app.quri.ai/trials/NCT07503587/evaluating-the-efficacy-and-safety-of-of-hsk44459-in-people- 2026-04-03T00:37:23.862Z weekly 0.7 https://app.quri.ai/trials/NCT07503405/phase-2a-study-of-the-efficacy-and-safety-of-trx-100-in-a-hu 2026-04-03T00:37:37.221Z weekly 0.7 https://app.quri.ai/trials/NCT07502664/development-and-evaluation-of-functional-visual-field-and-na 2026-04-03T00:36:55.808Z weekly 0.7 https://app.quri.ai/trials/NCT07503873/a-study-to-evaluate-pharmacokinetics-pk-and-safety-of-subcut 2026-04-03T00:37:21.894Z weekly 0.7 https://app.quri.ai/trials/NCT07502534/a-clinical-study-comparing-the-bioequivalence-of-ibi3027-and 2026-04-03T00:37:18.102Z weekly 0.7 https://app.quri.ai/trials/NCT07503210/amaze-12-a-research-study-investigating-how-well-the-medicin 2026-04-03T00:37:58.451Z weekly 0.7 https://app.quri.ai/trials/NCT07502456/clareon-truplus-single-arm-study 2026-04-03T00:36:58.417Z weekly 0.7 https://app.quri.ai/trials/NCT07502612/evaluation-of-medication-tapering-on-the-sensitivity-of-the- 2026-04-03T00:37:59.601Z weekly 0.7 https://app.quri.ai/trials/NCT07502716/compassionate-use-of-ubamatamab 2026-04-03T00:37:33.937Z weekly 0.7 https://app.quri.ai/trials/NCT07503340/a-study-to-evaluate-pharmacokinetics-safety-tolerability-imm 2026-04-03T00:37:53.693Z weekly 0.7 https://app.quri.ai/trials/NCT07501403/impact-of-protein-formulations-on-the-stimulation-of-muscle- 2026-04-02T00:35:32.950Z weekly 0.7 https://app.quri.ai/trials/NCT07501234/safety-and-feasibility-study-of-the-mitrafix-transcatheter-m 2026-04-02T00:35:18.382Z weekly 0.7 https://app.quri.ai/trials/NCT07502313/evacuation-time-and-tourniquet-use-as-risk-factors-for-ptsd- 2026-04-02T00:34:34.021Z weekly 0.7 https://app.quri.ai/trials/NCT07502222/a-study-to-evaluate-the-efficacy-and-safety-of-ak139-in-pati 2026-04-02T00:35:45.879Z weekly 0.7 https://app.quri.ai/trials/NCT07500506/a-study-to-learn-about-the-safety-tolerability-and-immunogen 2026-04-02T00:35:30.679Z weekly 0.7 https://app.quri.ai/trials/NCT07501442/clinical-trial-evaluating-the-efficacy-and-safety-of-uracil- 2026-04-02T00:34:54.626Z weekly 0.7 https://app.quri.ai/trials/NCT07499193/study-of-blinking-as-a-function-of-tear-film-quality 2026-04-02T00:34:47.025Z weekly 0.7 https://app.quri.ai/trials/NCT07501559/a-phase-ib-ii-clinical-trial-to-evaluate-the-safety-and-effi 2026-04-02T00:34:45.232Z weekly 0.7 https://app.quri.ai/trials/NCT07500727/skeletal-muscle-aging-and-responsiveness-in-aged-people-with 2026-04-02T00:35:33.158Z weekly 0.7 https://app.quri.ai/trials/NCT07501455/comparison-of-the-effects-of-oral-hygiene-regimens-on-clinic 2026-04-02T00:34:47.215Z weekly 0.7 https://app.quri.ai/trials/NCT07500025/categorizing-patient-risk-for-tricuspid-regurgitation-tr-int 2026-04-02T00:35:19.107Z weekly 0.7 https://app.quri.ai/trials/NCT07501039/a-phase-1-study-of-blkr201-in-healthy-adult-participants 2026-04-02T00:35:16.959Z weekly 0.7 https://app.quri.ai/trials/NCT07501702/a-phase-2-study-to-evaluate-povetacicept-in-adults-with-gene 2026-04-02T00:35:54.031Z weekly 0.7 https://app.quri.ai/trials/NCT07499232/a-study-of-guselkumab-versus-risankizumab-in-participants-wi 2026-04-02T00:35:39.462Z weekly 0.7 https://app.quri.ai/trials/NCT07501819/sympathetic-ablation-for-ventricular-arrhythmias 2026-04-02T00:35:33.768Z weekly 0.7 https://app.quri.ai/trials/NCT07500311/comparison-of-performance-using-med-el-automatic-sound-manag 2026-04-02T00:34:57.865Z weekly 0.7 https://app.quri.ai/trials/NCT07499050/a-study-of-multiple-doses-of-orally-administered-ro7795081-i 2026-04-02T00:34:38.571Z weekly 0.7 https://app.quri.ai/trials/NCT07501832/a-phase-iii-clinical-study-to-evaluate-the-efficacy-and-safe 2026-04-02T00:35:07.883Z weekly 0.7 https://app.quri.ai/trials/NCT07499180/a-study-on-body-posture-and-eye-movements-during-screen-usag 2026-04-02T00:34:51.738Z weekly 0.7 https://app.quri.ai/trials/NCT07500207/a-phase-iii-clinical-trial-on-immunogenicity-and-safety-of-l 2026-04-02T00:35:17.984Z weekly 0.7 https://app.quri.ai/trials/NCT07502001/influence-of-hdm1005-on-gastric-emptying-and-pharmacokinetic 2026-04-02T00:35:55.306Z weekly 0.7 https://app.quri.ai/trials/NCT07499440/safety-and-efficacy-of-hb-1-for-ptsd-a-multi-center-randomiz 2026-04-02T00:34:44.142Z weekly 0.7 https://app.quri.ai/trials/NCT07501052/study-of-the-scd411-prefilled-syringe-for-treating-adults-wi 2026-04-02T00:34:56.328Z weekly 0.7 https://app.quri.ai/trials/NCT07499102/ck0801-for-treatment-of-aplastic-anemia 2026-04-02T00:34:30.500Z weekly 0.7 https://app.quri.ai/trials/NCT07499115/efficacy-of-a-toothpaste-in-reducing-plaque-gingivitis-and-g 2026-04-02T00:35:18.751Z weekly 0.7 https://app.quri.ai/trials/NCT07502287/dual-target-gd2-b7-h3-car-nk-cells-for-pediatric-relapsed-or 2026-04-02T00:35:38.421Z weekly 0.7 https://app.quri.ai/trials/NCT07499674/evaluation-of-the-safety-and-efficacy-of-abenacianine-vgt-30 2026-04-02T00:34:44.333Z weekly 0.7 https://app.quri.ai/trials/NCT07502144/a-phase-i-study-comparing-the-safety-pharmacokinetics-and-re 2026-04-02T00:34:31.532Z weekly 0.7 https://app.quri.ai/trials/NCT07501312/remote-microphone-performance-comparison-in-adults-with-hear 2026-04-02T00:35:40.045Z weekly 0.7 https://app.quri.ai/trials/NCT07500987/phase-i-study-of-111in-fpi-2107-in-egfr-mutation-positive-ns 2026-04-02T00:34:56.898Z weekly 0.7 https://app.quri.ai/trials/NCT07499362/study-of-pimicotinib-in-japanese-participants-with-tenosynov 2026-04-02T00:34:30.905Z weekly 0.7 https://app.quri.ai/trials/NCT07499258/axonics-r20-post-market-clinical-follow-up-pmcf-study-for-th 2026-04-02T00:35:59.228Z weekly 0.7 https://app.quri.ai/trials/NCT05514028/evaluation-of-salivary-rnas-in-the-presence-of-an-adnexal-ma 2026-04-02T00:35:10.430Z weekly 0.7 https://app.quri.ai/trials/NCT07499700/a-clinical-study-of-bat4406f-injection-in-patients-with-mini 2026-04-02T00:35:47.864Z weekly 0.7 https://app.quri.ai/trials/NCT07499544/a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-lib 2026-04-02T00:36:05.764Z weekly 0.7 https://app.quri.ai/trials/NCT07500337/day-4-embryo-defragmentation-blastocyst-rate-and-clinical-ou 2026-04-02T00:34:38.129Z weekly 0.7 https://app.quri.ai/trials/NCT07501299/heartbeam-ecg-registry 2026-04-02T00:35:29.728Z weekly 0.7 https://app.quri.ai/trials/NCT07500181/a-phase-i-study-to-evaluate-the-safety-tolerability-and-phar 2026-04-02T00:35:57.794Z weekly 0.7 https://app.quri.ai/trials/NCT07499310/the-safety-and-effectiveness-of-q-therapeutic-system-frequen 2026-04-02T00:35:26.473Z weekly 0.7 https://app.quri.ai/trials/NCT07500090/a-phase-3-efficacy-and-safety-study-of-hbs-301-in-participan 2026-04-02T00:35:31.639Z weekly 0.7 https://app.quri.ai/trials/NCT07500220/dual-target-gpc3-b7-h3-car-nk-cells-for-advanced-hcc 2026-04-02T00:35:13.754Z weekly 0.7 https://app.quri.ai/trials/NCT07499908/phase-1-trial-to-evaluate-150-mg-subcutaneous-cit-013 2026-04-02T00:35:52.717Z weekly 0.7 https://app.quri.ai/trials/NCT07500714/integrating-digital-phenotypes-and-ai-driven-cognitive-behav 2026-04-02T00:35:46.685Z weekly 0.7 https://app.quri.ai/trials/NCT07501949/h-wave-device-stimulation-for-post-operative-rotator-cuff-re 2026-04-02T00:34:56.533Z weekly 0.7 https://app.quri.ai/trials/NCT07502300/a-study-comparing-bl-b01d1-combined-with-tislelizumab-versus 2026-04-02T00:35:39.053Z weekly 0.7 https://app.quri.ai/trials/NCT07472270/phase-1-clinical-trial-evaluation-of-the-safety-and-prelimin 2026-03-30T13:39:20.547Z weekly 0.7 https://app.quri.ai/trials/NCT06411899,NCT06411379/sonelokimab-in-moderate-to-severe-hs-long-term-results-throu 2026-03-29T09:36:39.559Z weekly 0.7 https://app.quri.ai/trials/ASC-CT-0000000538964-1.0-1749035152/phase-i-ii-first-in-human-trial-of-vg801-gene-therapy-in-pat 2026-03-29T08:35:32.899Z weekly 0.7 https://app.quri.ai/trials/NCT2000031055/a-phase-ii-randomized-trial-of-adjuvant-therapy-with-pembrol 2026-03-29T06:53:25.460Z weekly 0.7 https://app.quri.ai/trials/CTRI/2022/05/042521/a-prospective-multicenter-single-arm-phase-iv-study-to-asses 2026-03-29T06:50:01.443Z weekly 0.7 https://app.quri.ai/trials/NCT07496957/preserflo-microshunt-implantation-versus-trabeculectomy-in-m 2026-03-29T05:07:02.087Z weekly 0.7 https://app.quri.ai/trials/NCT03169231/longeveron-results-of-phase-2b-clinical-trial-demonstrating- 2026-03-29T04:55:48.943Z weekly 0.7 https://app.quri.ai/trials/HIC#2000039526/a-single-arm-phase-ii-study-of-sequential-therapy-with-curat 2026-03-29T04:24:45.881Z weekly 0.7 https://app.quri.ai/trials/NCT01817530/safety-and-efficacy-in-premenopausal-women-with-heavy-menstr 2026-03-29T04:17:01.964Z weekly 0.7 https://app.quri.ai/trials/KCT0010404/postoperative-pain-control-after-cesarean-section-by-continu 2026-03-29T03:35:23.099Z weekly 0.7 https://app.quri.ai/trials/NCT07496086/effects-of-ultrasound-guided-external-oblique-intercostal-bl 2026-03-29T03:22:29.854Z weekly 0.7 https://app.quri.ai/trials/NCT05193929/a-clinical-investigation-evaluating-wound-closure-with-optip 2026-03-29T03:08:28.573Z weekly 0.7 https://app.quri.ai/trials/NCT03812263/a-clinical-trial-to-evaluate-the-safety-and-efficacy-of-rp-l 2026-03-29T02:49:54.689Z weekly 0.7 https://app.quri.ai/trials/NCT04921345/pharmacokinetics-safety-and-efficacy-of-nemolizumab-in-child 2026-03-29T02:16:01.328Z weekly 0.7 https://app.quri.ai/trials/NCT07471997/efficacy-of-transseptal-and-transconjunctival-triamcinolone- 2026-03-29T01:58:14.306Z weekly 0.7 https://app.quri.ai/trials/NCT07305298/mirabegron-in-patients-with-age-related-macular-degeneration 2026-03-29T01:22:37.635Z weekly 0.7 https://app.quri.ai/trials/NCT01768858/assessment-of-rheumatoid-arthritis-psoriatic-arthritis-ankyl 2026-03-29T00:47:22.686Z weekly 0.7 https://app.quri.ai/trials/NCT2000040887/a-phase-ib-ii-multi-site-open-label-dose-finding-trial-to-ev 2026-03-29T00:36:44.848Z weekly 0.7 https://app.quri.ai/trials/NCT02682641/ibrutinib-in-combination-with-rituximab-in-patients-with-ind 2026-03-30T00:32:48.496Z weekly 0.7 https://app.quri.ai/trials/NCT07494669/proteomics-and-physiological-parameters-predicting-complicat 2026-03-30T00:32:29.365Z weekly 0.7 https://app.quri.ai/trials/20250552/a-phase-1b-2-open-label-study-to-evaluate-the-safety-tolerab 2026-03-29T00:31:39.023Z weekly 0.7 https://app.quri.ai/trials/NCT06013475/real-world-analysis-of-androgen-receptor-inhibitors-in-us-pa 2026-03-29T00:29:26.001Z weekly 0.7 https://app.quri.ai/trials/NCT06615511/a-phase-1-open-label-multiple-ascending-dose-basket-study-to 2026-03-29T00:26:30.154Z weekly 0.7 https://app.quri.ai/trials/HIC #2000039112/a-single-arm-phase-ii-trial-of-circulating-tumor-dna-guided- 2026-03-29T00:23:53.670Z weekly 0.7 https://app.quri.ai/trials/NCT07464340/bioequivalence-and-adhesion-assessment-between-two-rivastigm 2026-03-29T00:07:45.884Z weekly 0.7 https://app.quri.ai/trials/NCT07412821/a-phase-1b-study-of-adenylosuccinic-acid-asa-001-for-adenylo 2026-03-28T20:13:25.305Z weekly 0.7 https://app.quri.ai/trials/2025-524061-24-01/study-to-compare-drug-availability-in-the-bloodstream-of-two 2026-03-28T19:19:17.849Z weekly 0.7 https://app.quri.ai/trials/NCT07487714/randomized-study-of-integrated-assessment-of-amiodarone-effe 2026-03-28T19:17:28.498Z weekly 0.7 https://app.quri.ai/trials/NCT07492173/bioequivalence-study-of-trifluridine-and-tipiracil-hydrochlo 2026-03-28T19:15:30.267Z weekly 0.7 https://app.quri.ai/trials/NCT07493031/a-phase-study-of-hw252001-in-healthy-subjects 2026-03-28T17:20:52.162Z weekly 0.7 https://app.quri.ai/trials/NCT02248844/safety-and-effectiveness-of-botox-for-lateral-canthal-lines- 2026-03-28T16:58:14.716Z weekly 0.7 https://app.quri.ai/trials/NCT04615403/safety-and-feasibility-of-the-exchange-procedure-for-the-tra 2026-03-28T16:38:17.973Z weekly 0.7 https://app.quri.ai/trials/2025-522578-35/clinical-trials-in-the-european-union-ema 2026-03-28T15:55:03.292Z weekly 0.7 https://app.quri.ai/trials/NCT06098677/effect-of-carotenoids-supplementation-on-visual-function-in- 2026-03-28T15:31:24.714Z weekly 0.7 https://app.quri.ai/trials/NCT07497672/evaluation-of-novel-spectacles-intended-for-myopia-managemen 2026-03-28T15:23:16.170Z weekly 0.7 https://app.quri.ai/trials/NCT07494136/dose-dependent-steroid-injections 2026-03-28T15:09:32.465Z weekly 0.7 https://app.quri.ai/trials/NCT07498023/experimental-group-intervention-patients-will-receive-the-ca 2026-03-28T15:05:37.248Z weekly 0.7 https://app.quri.ai/trials/NCT07494955/effect-of-pre-spinal-mindfulness-based-breathing-exercise-on 2026-03-28T13:39:11.545Z weekly 0.7 https://app.quri.ai/trials/NCT07491783/a-multicenter-open-label-phase-ii-clinical-trial-to-evaluate 2026-03-28T12:38:13.329Z weekly 0.7 https://app.quri.ai/trials/NCT07493382/retlirafusp-alfa-injection-combined-chemotherapy-for-periope 2026-03-28T12:34:32.948Z weekly 0.7 https://app.quri.ai/trials/NCT00566722/open-label-study-of-adalimumab-in-subjects-who-have-a-sub-op 2026-03-28T11:16:22.651Z weekly 0.7 https://app.quri.ai/trials/NCT07497971/utilizing-electronic-modules-to-educate-on-sexual-health-pra 2026-03-28T11:15:59.538Z weekly 0.7 https://app.quri.ai/trials/CTRI/2025/04/085455/comparative-efficacy-and-safety-of-once-weekly-semaglutide-f 2026-03-28T11:11:24.561Z weekly 0.7 https://app.quri.ai/trials/NCT06874738/real-world-effectiveness-and-safety-of-liuwei-dihuang-in-com 2026-03-28T11:02:16.457Z weekly 0.7 https://app.quri.ai/trials/NCT07498998/glucocorticoid-ozone-and-5-dextrose-local-injection-for-pain 2026-03-28T09:08:09.582Z weekly 0.7 https://app.quri.ai/trials/NCT07495956/clonal-fetal-mesenchymal-stem-cells-cfmscs-therapy-for-type- 2026-03-28T07:56:18.853Z weekly 0.7 https://app.quri.ai/trials/PACTR20201081921856/phase-iib-study-of-etvax-in-gambian-children 2026-03-28T06:26:48.661Z weekly 0.7 https://app.quri.ai/trials/IND No. 179145/a-phase-1-multicenter-open-label-dose-escalation-study-of-st 2026-03-28T05:44:19.373Z weekly 0.7 https://app.quri.ai/trials/NCT07495150/efficacy-and-safety-of-intracalvariosseous-combined-with-int 2026-03-28T05:31:32.345Z weekly 0.7 https://app.quri.ai/trials/NCT07498634/a-multicenter-randomized-double-blind-placebo-controlled-pha 2026-03-28T05:18:23.533Z weekly 0.7 https://app.quri.ai/trials/NCT07489040/shape-pilot-trial-skin-health-and-allergy-prevention-exposur 2026-03-28T05:00:36.528Z weekly 0.7 https://app.quri.ai/trials/NCT07487506/evaluation-and-assessment-for-communicable-diseases-in-migra 2026-03-28T04:53:24.689Z weekly 0.7 https://app.quri.ai/trials/NCT07467408/treatment-of-mechanical-low-back-pain-with-high-intensity-fo 2026-03-28T03:10:01.806Z weekly 0.7 https://app.quri.ai/trials/NCT07495579/lenvatinib-or-regorafenib-for-advanced-hepatocellular-carcin 2026-03-28T03:01:39.028Z weekly 0.7 https://app.quri.ai/trials/NCT04992832/prime-hfref-trial-a-randomized-double-blind-multi-dose-umbil 2026-03-28T02:30:35.471Z weekly 0.7 https://app.quri.ai/trials/HLX701-CRC201/first-patient-dosed-in-a-phase-1b-2-clinical-trial-of-hlx701 2026-03-28T02:17:18.366Z weekly 0.7 https://app.quri.ai/trials/NCT07494266/safety-of-a-healthy-plant-based-diet-with-higher-potassium-c 2026-03-28T01:58:32.845Z weekly 0.7 https://app.quri.ai/trials/NCT01157364/safety-and-efficacy-of-a-new-ophthalmic-formulation-of-bimat 2026-03-28T01:50:29.581Z weekly 0.7 https://app.quri.ai/trials/NCT00661479/an-exploratory-study-to-evaluate-the-safety-of-brimonidine-i 2026-03-28T01:36:27.520Z weekly 0.7 https://app.quri.ai/trials/NCT07473557/clinical-outcomes-of-the-use-of-a-femtosecond-laser-on-an-im 2026-03-28T01:09:19.497Z weekly 0.7 https://app.quri.ai/trials/NCT07497737/omt-for-adhesive-capsulitis 2026-03-28T00:58:10.850Z weekly 0.7 https://app.quri.ai/trials/NCT07496203/the-effectiveness-of-bety-in-knee-osteoarthritis-with-intra- 2026-03-28T00:52:21.225Z weekly 0.7 https://app.quri.ai/trials/NCT07498465/a-study-to-find-the-highest-dose-of-sndx-5613-revumenib-as-a 2026-03-30T00:32:56.793Z weekly 0.7 https://app.quri.ai/trials/NCT07498205/comparing-momelotinib-and-ruxolitinib-in-people-with-untreat 2026-03-30T00:32:30.398Z weekly 0.7 https://app.quri.ai/trials/NCT07498478/efficacy-and-safety-of-tinengotinib-tablets-combined-with-fu 2026-03-30T00:32:40.079Z weekly 0.7 https://app.quri.ai/trials/NCT07495514/a-study-to-evaluate-the-effect-of-food-on-the-pharmacokineti 2026-03-30T00:32:27.481Z weekly 0.7 https://app.quri.ai/trials/NCT07494201/mimicc-study-in-patients-with-colorectal-cancer 2026-03-30T00:32:30.600Z weekly 0.7 https://app.quri.ai/trials/NCT00738439/prospective-multi-center-adult-spinal-deformity-outcomes-dat 2026-03-30T00:32:24.699Z weekly 0.7 https://app.quri.ai/trials/NCT07497074/jskn033-combination-therapy-in-subjects-with-advanced-cervic 2026-03-30T00:32:41.545Z weekly 0.7 https://app.quri.ai/trials/NCT07496229/assessing-treatment-of-t-cell-lymphoma-with-gw5282-in-combin 2026-03-30T00:32:56.181Z weekly 0.7 https://app.quri.ai/trials/NCT07493876/enhanced-recovery-after-surgery-eras-in-patients-with-perito 2026-03-28T00:35:16.694Z weekly 0.7 https://app.quri.ai/trials/NCT07495865/post-market-clinical-follow-up-pmcf-study-of-safety-and-perf 2026-03-30T00:32:24.513Z weekly 0.7 https://app.quri.ai/trials/NCT05928416/als-diagnosis-from-a-saliva-sample-a-non-coding-rna-analysis 2026-03-30T00:32:58.669Z weekly 0.7 https://app.quri.ai/trials/NCT07494448/phase-ib-ii-study-of-zanidatamab-plus-tucatinib-and-chemothe 2026-03-30T00:32:28.761Z weekly 0.7 https://app.quri.ai/trials/NCT07497386/a-trial-of-trastuzumab-rezetecan-in-unresectable-locally-rec 2026-03-30T00:32:49.691Z weekly 0.7 https://app.quri.ai/trials/NCT07498725/a-study-to-evaluate-the-safety-tolerability-and-preliminary- 2026-03-30T00:32:43.384Z weekly 0.7 https://app.quri.ai/trials/NCT06939296/a-research-study-of-vct220-in-adult-chinese-participants-wit 2026-03-30T00:32:46.125Z weekly 0.7 https://app.quri.ai/trials/NCT07494747/evaluation-of-the-effect-of-the-toothpaste-on-delicate-gums 2026-03-30T00:33:07.542Z weekly 0.7 https://app.quri.ai/trials/NCT07494058/a-study-of-home-vs-hospital-treatment-in-people-with-fabry-g 2026-03-30T00:33:07.533Z weekly 0.7 https://app.quri.ai/trials/NCT07497815/artificial-intelligence-assisted-diagnosis-in-ophthalmology 2026-04-03T00:35:57.198Z weekly 0.7 https://app.quri.ai/trials/NCT07497880/efficacy-and-safety-of-oral-kai-7535-in-adult-participants-l 2026-03-30T00:33:03.746Z weekly 0.7 https://app.quri.ai/trials/NCT05028166/individual-patient-compassionate-use-of-mirdametinib 2026-03-30T00:32:48.688Z weekly 0.7 https://app.quri.ai/trials/NCT07498426/a-study-to-evaluate-the-efficacy-of-nio752-in-participants-w 2026-03-30T00:32:15.589Z weekly 0.7 https://app.quri.ai/trials/NCT07497984/itm11-expanded-access-program 2026-03-30T00:31:45.841Z weekly 0.7 https://app.quri.ai/trials/NCT07497087/a-study-to-test-whether-nerandomilast-helps-people-with-syst 2026-04-03T00:32:52.153Z weekly 0.7 https://app.quri.ai/trials/NCT07495930/pharmacokinetic-characteristics-safety-and-immunogenicity-of 2026-04-03T00:35:59.385Z weekly 0.7 https://app.quri.ai/trials/NCT07496567/a-clinical-trial-of-eye201-mk-8748-in-people-with-macular-de 2026-04-03T00:36:27.460Z weekly 0.7 https://app.quri.ai/trials/NCT07495787/magnetic-compression-anastomosis-procedure-for-partial-jejun 2026-03-30T00:31:45.371Z weekly 0.7 https://app.quri.ai/trials/NCT07495033/phase-iii-clinical-trial-of-telitacicept-injection-in-the-tr 2026-03-30T00:31:59.564Z weekly 0.7 https://app.quri.ai/trials/NCT07497854/a-study-to-learn-about-the-study-medicine-nurtec-odt-75-mg-a 2026-03-30T00:32:24.318Z weekly 0.7 https://app.quri.ai/trials/NCT07497464/validity-of-an-open-access-handedness-recognition-task-in-st 2026-03-30T00:32:01.609Z weekly 0.7 https://app.quri.ai/trials/NCT07497321/safety-and-performance-of-a-pelvic-floor-mesh-implant-for-la 2026-03-30T00:32:12.467Z weekly 0.7 https://app.quri.ai/trials/NCT07494409/a-study-of-and017-to-evaluate-efficacy-and-safety-in-dialysi 2026-03-30T00:31:49.047Z weekly 0.7 https://app.quri.ai/trials/NCT07496164/a-clinical-study-assessing-the-maximum-maxillary-bite-force- 2026-03-30T00:32:16.844Z weekly 0.7 https://app.quri.ai/trials/NCT07498218/phase-1-study-of-velgraft-a-living-cellular-construct-in-the 2026-04-03T00:37:35.828Z weekly 0.7 https://app.quri.ai/trials/NCT07495852/trial-to-evaluate-the-safety-and-efficacy-of-the-second-gene 2026-04-02T00:35:14.553Z weekly 0.7 https://app.quri.ai/trials/NCT07114393/optimization-of-complex-percutaneous-coronary-intervention-w 2026-03-30T00:31:33.816Z weekly 0.7 https://app.quri.ai/trials/NCT07496372/efficacy-and-safety-of-human-induced-pluripotent-stem-cell-d 2026-03-30T00:31:32.721Z weekly 0.7 https://app.quri.ai/trials/NCT07498712/effect-of-l-reuteri-lm1063-on-sleep-health-improvement 2026-03-30T00:31:29.773Z weekly 0.7 https://app.quri.ai/trials/NCT07497503/a-study-of-b-3e07-and-forsteo-in-healthy-adult-female-partic 2026-03-30T00:31:28.445Z weekly 0.7 https://app.quri.ai/trials/NCT07494656/a-retrospective-observational-study-of-epidemiology-and-outc 2026-03-30T00:31:27.850Z weekly 0.7 https://app.quri.ai/trials/NCT07495813/a-study-to-see-how-ro7763505-works-and-how-safe-it-is-when-g 2026-03-30T00:31:20.438Z weekly 0.7 https://app.quri.ai/trials/NCT07494045/pharmacokinetics-pharmacodynamics-safety-and-tolerability-ev 2026-04-02T00:35:33.552Z weekly 0.7 https://app.quri.ai/trials/NCT07496450/a-study-of-mrna-1018-h5-pandemic-influenza-vaccine-in-health 2026-03-30T00:31:15.365Z weekly 0.7 https://app.quri.ai/trials/NCT07498647/clinical-trial-of-br2251-tablets-for-patients-with-primary-g 2026-03-30T00:31:12.146Z weekly 0.7 https://app.quri.ai/trials/NCT07494435/phase-2-study-of-wgi-0301-plus-nivolumab-in-patients-with-hc 2026-03-30T00:31:11.486Z weekly 0.7 https://app.quri.ai/trials/NCT07494175/study-on-the-mass-balance-of-14c-hrs-9190-for-injection-in-h 2026-03-30T00:31:04.842Z weekly 0.7 https://app.quri.ai/trials/NCT07494305/multicenter-study-to-assess-the-efficacy-and-safety-of-lb-10 2026-03-30T00:31:02.096Z weekly 0.7 https://app.quri.ai/trials/NCT07495202/a-clinical-trial-evaluating-the-monkeypox-recombinant-protei 2026-03-30T00:30:58.229Z weekly 0.7 https://app.quri.ai/trials/NCT07496021/safety-and-efficacy-of-l-lactis-ckdb001-in-subjects-with-ear 2026-04-02T00:36:06.206Z weekly 0.7 https://app.quri.ai/trials/NCT07498335/study-to-assess-the-efficacy-pharmacokinetics-safety-and-tol 2026-04-03T00:34:19.593Z weekly 0.7 https://app.quri.ai/trials/NCT05066230/phase-3-glow2-study-of-zenkuda-in-diabetic-retinopathy 2026-03-27T03:39:28.962Z weekly 0.7 https://app.quri.ai/trials/NCT06922838/effects-of-multisensory-stimulation-based-on-immersive-virtu 2026-03-27T03:33:34.798Z weekly 0.7 https://app.quri.ai/trials/ChiCTR2300076554/the-effect-of-text-messaging-on-the-postoperative-pain-exper 2026-03-27T03:32:53.743Z weekly 0.7 https://app.quri.ai/trials/NCT04975763/foods-fortified-with-soybean-or-palm-oil-show-no-effect-on-i 2026-03-27T01:24:16.207Z weekly 0.7 https://app.quri.ai/trials/NCT03656029/potency-related-effects-of-smoked-cannabis-on-simulated-driv 2026-03-27T01:17:38.080Z weekly 0.7 https://app.quri.ai/trials/NCT01642212, NCT02605837/effect-of-budesonide-oral-suspension-on-time-to-first-dyspha 2026-03-27T01:16:02.973Z weekly 0.7 https://app.quri.ai/trials/NCT07482865/routine-versus-provisional-distal-perfusion-catheter-placeme 2026-03-27T00:45:35.274Z weekly 0.7 https://app.quri.ai/trials/NCT04065490/lightsite-iii-trial 2026-03-27T00:27:37.835Z weekly 0.7 https://app.quri.ai/trials/NCT07490535/this-is-a-single-center-open-label-prospective-study-to-eval 2026-03-27T00:26:23.503Z weekly 0.7 https://app.quri.ai/trials/NCT07491068/the-accuracy-and-efficacy-of-large-language-model-written-ho 2026-03-26T04:46:21.572Z weekly 0.7 https://app.quri.ai/trials/EudraCT:2020-003633-38/a-first-in-human-phase-1-1b-randomized-trial-evaluating-the- 2026-03-26T04:37:08.333Z weekly 0.7 https://app.quri.ai/trials/NCT04652726/efficacy-and-safety-of-inclisiran-in-adolescents-with-hetero 2026-03-26T04:20:39.596Z weekly 0.7 https://app.quri.ai/trials/EL 0219-2758 PC MAD/research-study-for-healthy-males-females-ages-18-65 2026-03-26T04:04:05.698Z weekly 0.7 https://app.quri.ai/trials/NCT07487467/evaluation-of-autologous-adipose-derived-stromal-vascular-fr 2026-03-26T03:57:31.977Z weekly 0.7 https://app.quri.ai/trials/HIC#2000041378/a-phase-1-first-in-human-study-of-men2501-a-kif18a-inhibitor 2026-03-26T03:49:15.849Z weekly 0.7 https://app.quri.ai/trials/NCT02702492/first-in-human-phase-i-study-of-kpt-9274-a-first-in-class-du 2026-03-26T02:45:37.920Z weekly 0.7 https://app.quri.ai/trials/UMIN000060960/study-to-confirm-the-effect-of-food-containing-bifidobacteri 2026-03-26T02:36:45.814Z weekly 0.7 https://app.quri.ai/trials/NCT07492264/evaluation-of-the-effect-of-a-food-supplementation-with-a-co 2026-03-26T02:27:11.755Z weekly 0.7 https://app.quri.ai/trials/NCT06354257/combined-oral-contraceptive-drug-drug-interaction-study-with 2026-03-26T02:25:02.803Z weekly 0.7 https://app.quri.ai/trials/NCT02820363/a-prospective-randomized-multicenter-controlled-trial-of-cer 2026-03-26T02:06:51.291Z weekly 0.7 https://app.quri.ai/trials/FX-909-CLINPRO-1/fx-909-demonstrates-acceptable-safety-and-preliminary-antitu 2026-03-26T02:05:00.438Z weekly 0.7 https://app.quri.ai/trials/NCT04314661/influence-of-synovial-fluid-biochemical-markers-on-clinical- 2026-03-26T01:44:48.328Z weekly 0.7 https://app.quri.ai/trials/NCT04379700/potential-predictors-of-pain-and-stiffness-response-followin 2026-03-26T01:44:06.748Z weekly 0.7 https://app.quri.ai/trials/NCT05577403/mobilization-with-movement-enhances-early-rehabilitation-out 2026-03-26T01:42:22.627Z weekly 0.7 https://app.quri.ai/trials/NCT06992661/a-study-of-the-pharmacokinetics-and-safety-of-single-dose-in 2026-03-26T01:30:00.431Z weekly 0.7 https://app.quri.ai/trials/NCT03074513/atezolizumab-and-bevacizumab-in-treating-patients-with-rare- 2026-03-26T01:29:21.888Z weekly 0.7 https://app.quri.ai/trials/NCT07489287/a-phase-1-open-label-dose-escalation-study-evaluating-the-sa 2026-03-26T01:24:19.530Z weekly 0.7 https://app.quri.ai/trials/NCT03365947/arrowhead-receives-regulatory-clearance-to-begin-phase-1-2-s 2026-03-26T01:06:58.859Z weekly 0.7 https://app.quri.ai/trials/NCT07489521/arthrosemid-vs-steroid-for-the-management-knee-osteoarthriti 2026-03-26T00:53:27.837Z weekly 0.7 https://app.quri.ai/trials/CLNP023B12001B/an-open-label-non-randomized-extension-study-to-evaluate-the 2026-03-26T00:43:57.171Z weekly 0.7 https://app.quri.ai/trials/NCT06618092/evaluating-patient-and-professional-satisfaction-and-documen 2026-03-26T00:39:20.922Z weekly 0.7 https://app.quri.ai/trials/NCT07491484/impact-of-physical-functioning-on-patient-reported-outcomes- 2026-03-27T00:32:54.502Z weekly 0.7 https://app.quri.ai/trials/NCT07348588/intravitreal-adalimumab-in-inherited-and-degenerative-retina 2026-03-27T00:32:48.069Z weekly 0.7 https://app.quri.ai/trials/NCT07493304/treatment-and-secondary-prevention-of-venous-thromboembolism 2026-03-28T00:35:10.450Z weekly 0.7 https://app.quri.ai/trials/NCT07492628/dual-target-nectin-4-her2-car-nk-cells-in-advanced-urothelia 2026-03-28T00:34:47.522Z weekly 0.7 https://app.quri.ai/trials/NCT07492420/medcline-investigational-study-for-the-treatment-of-mild-osa 2026-03-30T00:31:04.440Z weekly 0.7 https://app.quri.ai/trials/NCT07493239/a-decentralized-clinical-study-evaluating-the-effectiveness- 2026-03-28T00:34:44.847Z weekly 0.7 https://app.quri.ai/trials/NCT07493512/trial-of-xaluritamig-in-adults-with-metastatic-castration-re 2026-03-28T00:34:45.273Z weekly 0.7 https://app.quri.ai/trials/NCT07491900/a-phase-1-study-of-hb2198-in-participants-with-moderately-to 2026-03-28T00:34:30.121Z weekly 0.7 https://app.quri.ai/trials/NCT07492992/home-ahcl-home-based-implementation-of-an-advanced-hybrid-cl 2026-04-03T00:36:52.148Z weekly 0.7 https://app.quri.ai/trials/NCT07493551/a-bioequivalence-study-of-pp3m-in-patients-with-schizophreni 2026-03-28T00:34:40.031Z weekly 0.7 https://app.quri.ai/trials/NCT07491952/continuous-dual-aspiration-technique-with-zoom-system-for-st 2026-04-03T00:34:36.306Z weekly 0.7 https://app.quri.ai/trials/NCT07492277/a-non-interventional-pmcf-study-evaluating-croma-revitalis-f 2026-03-28T00:34:52.579Z weekly 0.7 https://app.quri.ai/trials/NCT07493057/evaluate-the-efficacy-and-safety-of-gzr18-injection-in-obese 2026-03-30T00:31:57.376Z weekly 0.7 https://app.quri.ai/trials/NCT07493122/study-of-imc-s118ai-in-type-1-diabetes 2026-03-28T00:34:50.649Z weekly 0.7 https://app.quri.ai/trials/NCT07492706/safety-tolerability-and-immunogenicity-of-a-maternal-respira 2026-03-28T00:35:08.844Z weekly 0.7 https://app.quri.ai/trials/NCT05880641/use-of-shockwave-m5-l6-ivl-catheter-intravascular-lithotrips 2026-03-28T00:34:34.065Z weekly 0.7 https://app.quri.ai/trials/NCT07492381/a-prospective-single-arm-pilot-study-of-the-alpfa-bph-pfa-sy 2026-03-30T00:31:03.831Z weekly 0.7 https://app.quri.ai/trials/NCT07492888/nogapendekin-alfa-inbakicept-and-inkt-cells-for-critically-i 2026-03-28T00:35:10.256Z weekly 0.7 https://app.quri.ai/trials/NCT07493850/study-to-assess-the-efficacy-of-emc-cap-2025a-on-age-related 2026-04-03T00:33:18.214Z weekly 0.7 https://app.quri.ai/trials/NCT07492771/mp101-in-adults-with-acute-pseudomonas-aeruginosa-pneumonia 2026-04-02T00:35:53.837Z weekly 0.7 https://app.quri.ai/trials/NCT07493265/a-study-to-evaluate-the-efficacy-and-safety-of-e2086-in-adul 2026-03-28T00:35:00.072Z weekly 0.7 https://app.quri.ai/trials/NCT07492875/study-of-nogapendekin-alfa-inbakicept-and-inkt-cells-in-crit 2026-03-28T00:34:50.835Z weekly 0.7 https://app.quri.ai/trials/NCT05813678/a-long-term-post-marketing-safety-study-of-palynziq-in-patie 2026-03-28T00:34:20.749Z weekly 0.7 https://app.quri.ai/trials/NCT07492641/bgb-43395-plus-letrozole-versus-cdk4-6i-plus-letrozole-for-p 2026-03-28T00:34:16.956Z weekly 0.7 https://app.quri.ai/trials/NCT07493096/intensive-multimodal-neurorehabilitation-targeting-neuroplas 2026-03-28T00:34:51.971Z weekly 0.7 https://app.quri.ai/trials/NCT07492680/a-study-of-bms-986504-monotherapy-and-in-combination-with-ot 2026-03-28T00:34:36.417Z weekly 0.7 https://app.quri.ai/trials/NCT07492563/safety-and-effectiveness-of-tirzepatide-in-patients-with-obe 2026-03-28T00:34:23.463Z weekly 0.7 https://app.quri.ai/trials/NCT07493135/a-study-of-imv102-in-patients-with-relapsed-refractory-multi 2026-04-02T00:34:29.439Z weekly 0.7 https://app.quri.ai/trials/NCT07492303/a-phase-i-clinical-trial-of-absorbed-acellular-pertussis-two 2026-03-28T00:34:34.295Z weekly 0.7 https://app.quri.ai/trials/NCT07078552/from-blink-to-care-smartphone-video-based-functional-analysi 2026-03-26T00:04:39.587Z weekly 0.7 https://app.quri.ai/trials/NCT04902040/phase-1-study-of-plinabulin-in-combination-with-pd-1-inhibit 2026-03-25T16:01:35.118Z weekly 0.7 https://app.quri.ai/trials/NCT05599789/phase-2-study-of-plinabulin-in-combination-with-pembrolizuma 2026-03-25T16:01:34.809Z weekly 0.7 https://app.quri.ai/trials/NCT07463599/iterion-therapeutics-expands-clinical-development-of-tegaviv 2026-03-25T12:27:20.136Z weekly 0.7 https://app.quri.ai/trials/NCT04591431/strategic-research-collaboration-to-analyze-landmark-rome-ph 2026-03-25T12:16:32.696Z weekly 0.7 https://app.quri.ai/trials/AEMD-2022-06/aethlon-medical-advances-to-final-cohort-in-cancer-device-tr 2026-03-25T08:54:53.546Z weekly 0.7 https://app.quri.ai/trials/BCDA-03/cardiallo-cell-therapy-in-ischemic-heart-failure-bcda-03 2026-03-25T08:22:06.247Z weekly 0.7 https://app.quri.ai/trials/BCDA-02/cardiamp-autologous-cell-therapy-in-chronic-myocardial-ische 2026-03-25T08:22:06.105Z weekly 0.7 https://app.quri.ai/trials/NCT06062238/phase-iii-trial-of-the-m72-as01e-vaccine 2026-03-25T07:04:37.776Z weekly 0.7 https://app.quri.ai/trials/NCT07489430/a-phase-2-open-label-single-center-trial-to-assess-the-effic 2026-03-25T01:41:25.154Z weekly 0.7 https://app.quri.ai/trials/NCT07490496/phase-3-bunionectomy-study 2026-03-30T00:32:34.316Z weekly 0.7 https://app.quri.ai/trials/NCT07489651/re104-safety-and-efficacy-study-in-generalized-anxiety-disor 2026-03-27T00:32:35.301Z weekly 0.7 https://app.quri.ai/trials/NCT07489885/a-study-to-evaluate-d-2570-in-participants-with-moderate-to- 2026-03-30T00:32:32.006Z weekly 0.7 https://app.quri.ai/trials/NCT07491289/gs1-144-in-participants-with-hepatic-impairment-and-healthy- 2026-03-27T00:32:53.255Z weekly 0.7 https://app.quri.ai/trials/NCT07490418/tes-ht100-clinical-validation-for-brain-injury-screening-in- 2026-03-27T00:31:41.109Z weekly 0.7 https://app.quri.ai/trials/NCT07490262/a-study-to-evaluate-the-efficacy-and-safety-of-ibi310-and-si 2026-03-27T00:32:29.530Z weekly 0.7 https://app.quri.ai/trials/NCT07489209/a-dose-exploration-study-of-edp167-in-hofh 2026-03-30T00:32:12.256Z weekly 0.7 https://app.quri.ai/trials/NCT07490613/a-phase-i-study-of-shr-3836-in-patients-with-multiple-myelom 2026-03-27T00:32:15.490Z weekly 0.7 https://app.quri.ai/trials/NCT07489560/evaluation-of-the-safety-and-efficacy-of-dehydrated-human-am 2026-03-27T00:31:47.396Z weekly 0.7 https://app.quri.ai/trials/NCT07489586/a-clinical-study-of-ql1207h-injection-versus-aflibercept-for 2026-03-27T00:32:34.864Z weekly 0.7 https://app.quri.ai/trials/NCT05500066/tornier-hrs-humeral-reconstruction-system-study-revive 2026-04-02T00:35:52.968Z weekly 0.7 https://app.quri.ai/trials/NCT07491458/a-trial-to-investigate-safety-exposure-and-efficacy-of-hu6-c 2026-03-27T00:32:48.600Z weekly 0.7 https://app.quri.ai/trials/NCT07491497/a-phase-1-2-study-of-tri-611-in-alk-positive-nsclc 2026-03-28T00:35:08.051Z weekly 0.7 https://app.quri.ai/trials/NCT06423235/efficacy-and-safety-of-prunella-oral-liquid-in-the-treatment 2026-03-27T00:32:22.522Z weekly 0.7 https://app.quri.ai/trials/NCT07489495/a-clinical-study-of-belzutifan-mk-6482-and-zanzalintinib-in- 2026-03-27T00:32:12.680Z weekly 0.7 https://app.quri.ai/trials/NCT07489482/a-clinical-study-comparing-the-relative-bioavailability-and- 2026-03-27T00:32:57.151Z weekly 0.7 https://app.quri.ai/trials/NCT07491744/the-stroke-aetiology-and-vascular-disease-in-stroke-and-tia- 2026-03-27T00:32:58.838Z weekly 0.7 https://app.quri.ai/trials/NCT07490951/cluster-of-differentiation-19-cd19-b-cell-maturation-antigen 2026-03-27T00:31:58.555Z weekly 0.7 https://app.quri.ai/trials/NCT07489326/the-setpoint-system-safety-performance-post-approval-study 2026-03-27T00:32:50.147Z weekly 0.7 https://app.quri.ai/trials/NCT07491107/brazilian-prospective-registry-of-the-inspiron-evo-drug-elut 2026-04-02T00:35:28.517Z weekly 0.7 https://app.quri.ai/trials/NCT07489599/a-study-of-qlh2405-in-healthy-participants-and-participants- 2026-03-27T00:32:03.826Z weekly 0.7 https://app.quri.ai/trials/NCT07489196/a-phase-2-safety-and-efficacy-study-evaluating-cs-101-in-par 2026-03-27T00:31:57.121Z weekly 0.7 https://app.quri.ai/trials/NCT07490431/an-observational-study-to-learn-more-about-how-elinzanetant- 2026-03-27T00:31:56.276Z weekly 0.7 https://app.quri.ai/trials/NCT07489911/fixed-triple-inhaled-combination-in-asthmatic-patients-in-a- 2026-03-27T00:32:30.044Z weekly 0.7 https://app.quri.ai/trials/NCT04777734/pre-approval-access-for-efgartigimod-ph20-sc-in-adults-with- 2026-03-27T00:32:22.774Z weekly 0.7 https://app.quri.ai/trials/NCT07489573/study-of-efficacy-and-safety-of-secukinumab-in-chinese-adult 2026-03-27T00:31:42.096Z weekly 0.7 https://app.quri.ai/trials/NCT07491042/impact-of-sglt2-inhibitors-on-chronic-peritoneal-dialysis-pa 2026-03-27T00:32:39.620Z weekly 0.7 https://app.quri.ai/trials/NCT07490691/painhunting-therapy-for-interpersonal-loss-related-depressio 2026-03-27T00:32:53.521Z weekly 0.7 https://app.quri.ai/trials/NCT07489612/qls1410-in-participants-with-uncontrolled-hypertension 2026-03-27T00:33:02.916Z weekly 0.7 https://app.quri.ai/trials/NCT04447339/open-nipple-sparing-mastectomy-nsm 2026-03-27T00:32:16.238Z weekly 0.7 https://app.quri.ai/trials/NCT07490301/a-study-to-assess-intravenous-iv-telisotuzumab-adizutecan-in 2026-03-27T00:31:44.666Z weekly 0.7 https://app.quri.ai/trials/NCT06277362/peripheral-extreme-revascularization-in-no-option-patiens-wi 2026-03-27T00:32:00.234Z weekly 0.7 https://app.quri.ai/trials/NCT07489716/a-phase-ii-clinical-trial-of-shr-1826-for-non-small-cell-lun 2026-03-27T00:32:36.010Z weekly 0.7 https://app.quri.ai/trials/NCT07491445/study-of-daraxonrasib-and-daraxonrasib-gnp-as-first-line-tre 2026-03-27T00:31:40.396Z weekly 0.7 https://app.quri.ai/trials/NCT07491172/a-safety-and-tolerability-trial-evaluating-ctx310-in-partici 2026-03-27T00:32:57.998Z weekly 0.7 https://app.quri.ai/trials/NCT07489755/tgrx-678-chinese-phase-iii-in-chronic-myelogenous-leukemia-c 2026-03-27T00:32:01.772Z weekly 0.7 https://app.quri.ai/trials/NCT07482228/long-term-clinical-outcomes-after-retinal-artery-occlusion 2026-03-25T00:27:50.594Z weekly 0.7 https://app.quri.ai/trials/NCT06505239/double-blind-randomized-placebo-controlled-crossover-design- 2026-03-24T23:31:05.149Z weekly 0.7 https://app.quri.ai/trials/NCT07157735/first-parkinson-s-patients-treated-in-landmark-phase-2-trial 2026-03-24T20:39:32.235Z weekly 0.7 https://app.quri.ai/trials/NCT04206553/sanofi-and-regeneron-s-dupixent-approved-in-japan-as-the-fir 2026-03-24T07:24:03.239Z weekly 0.7 https://app.quri.ai/trials/KN026-007/phase-iii-clinical-study-of-anbenitamab-kn026-in-combination 2026-03-24T06:05:45.589Z weekly 0.7 https://app.quri.ai/trials/NEO212-01/phase-1-2-clinical-trial-for-neo212-the-company-s-novel-oral 2026-03-24T05:09:32.603Z weekly 0.7 https://app.quri.ai/trials/NCT05398796/phase-1-first-in-human-open-label-dose-escalation-trial-of-a 2026-03-24T04:58:13.603Z weekly 0.7 https://app.quri.ai/trials/HIC#2000041252/a-phase-1-dose-escalation-and-expansion-study-evaluating-the 2026-03-24T04:51:24.338Z weekly 0.7 https://app.quri.ai/trials/BCC020/a-dose-escalation-study-using-eflornithine-dfmo-and-amxt-150 2026-03-24T04:49:44.871Z weekly 0.7 https://app.quri.ai/trials/NCT04329494/multicenter-dose-de-escalation-phase-i-trial-of-pressurized- 2026-03-24T04:43:04.509Z weekly 0.7 https://app.quri.ai/trials/NCT06262100/safety-and-effectiveness-of-iota-carrageenan-eye-drops-for-t 2026-03-24T02:04:43.797Z weekly 0.7 https://app.quri.ai/trials/NCT07484776/metabolic-flexibility-in-patients-with-early-triple-negative 2026-03-24T01:43:33.270Z weekly 0.7 https://app.quri.ai/trials/NCT05489614/compare-pk-in-renal-impairment-vs-normal 2026-03-24T00:46:33.233Z weekly 0.7 https://app.quri.ai/trials/NCT05481411/compare-pk-in-hepatic-impairment-vs-normal 2026-03-24T00:46:32.535Z weekly 0.7 https://app.quri.ai/trials/NCT04987320/evaluate-pk-of-olpasiran-in-chinese-population 2026-03-24T00:46:31.688Z weekly 0.7 https://app.quri.ai/trials/NCT06411860/qtc-interval-study-single-supratherapeutic-dose-assess-qt-qt 2026-03-24T00:46:30.221Z weekly 0.7 https://app.quri.ai/trials/NCT04270760/sc-olpasiran-vs-placebo-change-in-lp-a-evaluate-change-in-lp 2026-03-24T00:46:27.806Z weekly 0.7 https://app.quri.ai/trials/NCT05841277/assess-pk-and-safety-in-renal-impairment-vs-normal-renal-fun 2026-03-24T00:46:24.526Z weekly 0.7 https://app.quri.ai/trials/NCT04914546/evaluate-safety-tolerability-pk-and-effect-on-lp-a-levels 2026-03-24T00:46:21.677Z weekly 0.7 https://app.quri.ai/trials/NCT07489170/innovative-web-based-service-platform-called-adult-wellbeing 2026-03-26T00:34:27.360Z weekly 0.7 https://app.quri.ai/trials/NCT07488260/evaluation-of-the-prelux-for-assessment-of-developmental-dys 2026-03-26T00:34:32.605Z weekly 0.7 https://app.quri.ai/trials/NCT07487896/a-study-of-yl201-versus-investigator-s-choice-of-chemotherap 2026-04-02T00:35:31.248Z weekly 0.7 https://app.quri.ai/trials/NCT07487389/zilganersen-expanded-access-program-for-individuals-with-ale 2026-03-26T00:34:31.442Z weekly 0.7 https://app.quri.ai/trials/NCT04339699/noblestitch-el-stitch-trial-is-a-pfo-comparative-trial 2026-03-26T00:33:57.269Z weekly 0.7 https://app.quri.ai/trials/NCT07332338/expanded-access-use-of-human-umbilical-cord-blood-regenecyte 2026-03-26T00:34:03.733Z weekly 0.7 https://app.quri.ai/trials/NCT07488884/open-label-phase-1-clinical-trial-of-neoadjuvant-nogapendeki 2026-03-26T00:34:20.547Z weekly 0.7 https://app.quri.ai/trials/NCT07486817/beamion-44-a-study-to-test-how-well-zongertinib-is-tolerated 2026-03-26T00:34:06.623Z weekly 0.7 https://app.quri.ai/trials/NCT07487545/safety-tolerability-pharmacokinetics-pharmacodynamics-and-im 2026-03-26T00:34:32.217Z weekly 0.7 https://app.quri.ai/trials/NCT07487194/global-utilization-and-registry-database-for-improved-preser 2026-03-26T00:33:59.502Z weekly 0.7 https://app.quri.ai/trials/NCT07489131/clinical-study-to-compare-efficacy-and-safety-of-avt29-and-e 2026-03-26T00:34:17.963Z weekly 0.7 https://app.quri.ai/trials/NCT07487103/efficacy-and-safety-of-qlg1090-vs-rybelsus-as-add-on-to-metf 2026-03-26T00:34:03.230Z weekly 0.7 https://app.quri.ai/trials/NCT07487064/galvanize-aliya-ex-pulsed-electric-field-pef-treat-and-resec 2026-03-26T00:34:41.536Z weekly 0.7 https://app.quri.ai/trials/NCT05318274/hypofractionated-radiation-therapy-vs-standard-treatment-in- 2026-03-26T00:34:13.773Z weekly 0.7 https://app.quri.ai/trials/NCT07487363/tb-500-thymosin-beta-4-17-23-fragment-for-cardiovascular-bio 2026-03-26T00:34:35.280Z weekly 0.7 https://app.quri.ai/trials/NCT07487597/functionally-enhanced-alpp-targeted-engineered-t-cells-in-ad 2026-03-26T00:33:59.900Z weekly 0.7 https://app.quri.ai/trials/NCT07488897/rig-101-trial-in-healthy-adults-and-adults-with-asthma 2026-03-26T00:34:29.785Z weekly 0.7 https://app.quri.ai/trials/NCT07486960/study-to-evaluate-tulisokibart-in-adults-with-psoriatic-arth 2026-03-26T00:33:44.974Z weekly 0.7 https://app.quri.ai/trials/NCT07488975/developing-microbial-therapy-for-masld-from-mechanism-to-cli 2026-03-26T00:34:21.256Z weekly 0.7 https://app.quri.ai/trials/NCT07488923/a-first-in-human-fih-phase-1-study-of-ml261-an-autologous-po 2026-04-03T00:36:13.836Z weekly 0.7 https://app.quri.ai/trials/NCT07488676/a-study-of-asp546c-in-adults-with-gastroesophageal-cancer-pa 2026-03-26T00:33:47.360Z weekly 0.7 https://app.quri.ai/trials/NCT07487766/the-safety-and-efficacy-of-xytrix-umbilical-cord-derived-mes 2026-04-02T00:35:57.585Z weekly 0.7 https://app.quri.ai/trials/NCT07487727/a-study-of-and017-to-evaluate-efficacy-and-safety-in-patient 2026-03-30T00:32:45.070Z weekly 0.7 https://app.quri.ai/trials/NCT07487376/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics 2026-03-26T00:34:28.605Z weekly 0.7 https://app.quri.ai/trials/NCT07488546/hcl001-cell-injection-for-decompensated-cirrhosis-a-phase-i- 2026-03-26T00:34:34.247Z weekly 0.7 https://app.quri.ai/trials/NCT07486934/efficacy-safety-and-tolerability-of-dyne-101-in-participants 2026-03-26T00:33:57.739Z weekly 0.7 https://app.quri.ai/trials/NCT07488585/this-study-tests-a-new-sound-blade-ultrasound-for-thyroid-sc 2026-03-26T00:34:36.498Z weekly 0.7 https://app.quri.ai/trials/NCT07487519/phase-ii-study-of-hlx43-monotherapy-or-combined-with-immune- 2026-03-26T00:34:05.711Z weekly 0.7 https://app.quri.ai/trials/NCT07489066/symbiotic-lung-10-a-study-to-learn-about-pf-08634404-alone-o 2026-03-26T00:34:22.329Z weekly 0.7 https://app.quri.ai/trials/NCT07487701/migraine-prevention-with-the-remote-electrical-neuromodulati 2026-03-26T00:34:22.095Z weekly 0.7 https://app.quri.ai/trials/NCT07487740/a-food-effect-study-to-evaluate-the-relative-bioavailability 2026-03-26T00:34:36.126Z weekly 0.7 https://app.quri.ai/trials/NCT05492500/a-phase-2-double-blind-randomized-placebo-controlled-4-arm-s 2026-03-24T00:23:32.159Z weekly 0.7 https://app.quri.ai/trials/NCT07215754/patient-profiles-and-early-response-in-patients-with-systemi 2026-03-23T16:57:43.843Z weekly 0.7 https://app.quri.ai/trials/NCT04770220, NCT04693520/phase-iii-apolloe4-trial-and-phase-ii-biomarker-long-term-ex 2026-03-23T16:46:45.191Z weekly 0.7 https://app.quri.ai/trials/NCT03790709/advancing-alzheimer-s-disease-care-convenience-for-both-pati 2026-03-23T15:56:55.029Z weekly 0.7 https://app.quri.ai/trials/NCT04678453, NCT06189963/combined-phase-1-troculeucel-data-demonstrating-dose-respons 2026-03-23T15:50:43.847Z weekly 0.7 https://app.quri.ai/trials/HPN-CTCL-04/results-from-a-pilot-study-of-hybryte-topical-synthetic-hype 2026-03-23T15:00:06.291Z weekly 0.7 https://app.quri.ai/trials/null/adipopharma-enters-clinic-with-first-in-class-therapy-target 2026-03-23T14:15:02.043Z weekly 0.7 https://app.quri.ai/trials/NCT06442761/phase-1-clinical-trial-evaluating-motixafortide-for-the-mobi 2026-03-23T13:40:21.756Z weekly 0.7 https://app.quri.ai/trials/NCT05618301/phase-1-clinical-trial-evaluating-motixafortide-for-cd34-hem 2026-03-23T13:40:21.465Z weekly 0.7 https://app.quri.ai/trials/Abstract #75099/four-year-efficacy-of-continuous-secukinumab-in-sunshine-sun 2026-03-23T11:31:10.788Z weekly 0.7 https://app.quri.ai/trials/Abstract #71668/early-symptom-improvement-with-remibrutinib-in-chronic-spont 2026-03-23T11:31:08.550Z weekly 0.7 https://app.quri.ai/trials/NCT05790694/first-in-human-phase-i-trial-of-hbm9378-also-known-as-skb378 2026-03-23T04:59:10.235Z weekly 0.7 https://app.quri.ai/trials/NCT07462663/shape-endo-multimodal-pre-surgical-optimization-in-patients- 2026-03-23T03:08:45.135Z weekly 0.7 https://app.quri.ai/trials/ISRCTN17592593/eat-up-trial-comparing-extended-antibiotics-and-hiprex-with- 2026-03-23T02:57:13.891Z weekly 0.7 https://app.quri.ai/trials/NCT05200936/safety-and-efficacy-of-repeated-low-dose-d-lysergic-acid-die 2026-03-23T02:49:27.639Z weekly 0.7 https://app.quri.ai/trials/EudraCT 2013-004653-25/clinical-evaluation-of-the-efficacy-and-safety-of-nasturtium 2026-03-23T02:44:24.158Z weekly 0.7 https://app.quri.ai/trials/DRKS00029292/randomized-comparative-multicenter-study-assessing-two-dispe 2026-03-23T02:33:20.450Z weekly 0.7 https://app.quri.ai/trials/NCT02484404/durvalumab-and-cediranib-with-and-without-olaparib-in-recurr 2026-03-23T02:31:42.917Z weekly 0.7 https://app.quri.ai/trials/NCT02467270/a-randomized-open-label-phase-2-trial-of-ponatinib-in-patien 2026-03-23T01:34:21.471Z weekly 0.7 https://app.quri.ai/trials/NCT07482670/efficacy-and-safety-of-camrelizumab-plus-rivoceranib-and-loc 2026-03-23T01:01:18.938Z weekly 0.7 https://app.quri.ai/trials/NCT05121441/ard-101-a-gut-restricted-tas2r-agonist-reduces-hunger-in-adu 2026-03-23T00:27:04.037Z weekly 0.7 https://app.quri.ai/trials/NCT07451197/family-focused-study-to-support-medication-for-opioid-use-di 2026-03-22T12:15:32.998Z weekly 0.7 https://app.quri.ai/trials/NCT07483996/cryoablation-versus-lumpectomy-in-early-stage-breast-cancer 2026-03-22T12:01:40.100Z weekly 0.7 https://app.quri.ai/trials/NCT06671912/alliance-a012301-lotam-a-randomized-phase-iii-clinical-trial 2026-03-22T12:01:08.198Z weekly 0.7 https://app.quri.ai/trials/NCT05496374/randomized-study-of-the-efficacy-safety-and-pharmacokinetics 2026-03-22T11:53:00.366Z weekly 0.7 https://app.quri.ai/trials/HIC#:2000041481/a-phase-1-open-label-study-to-evaluate-the-safety-tolerabili 2026-03-22T11:41:49.155Z weekly 0.7 https://app.quri.ai/trials/NCT06385964/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics 2026-03-22T11:39:17.591Z weekly 0.7 https://app.quri.ai/trials/NCT06050252/a-phase-ii-trial-of-durvalumab-with-gemcitabine-and-cisplati 2026-03-22T11:34:27.263Z weekly 0.7 https://app.quri.ai/trials/NCT07482319/a-phase-i-open-label-single-arm-clinical-study-of-gk01-cell- 2026-03-22T11:21:22.861Z weekly 0.7 https://app.quri.ai/trials/NCT03863184/mrd-driven-initial-therapy-of-acalabrutinib-and-lenalidomide 2026-03-22T09:14:26.122Z weekly 0.7 https://app.quri.ai/trials/NCT07485361/functional-near-infrared-spectroscopy-fnirs-for-disorders-of 2026-03-22T09:08:47.926Z weekly 0.7 https://app.quri.ai/trials/HIC#:2000028726/phase-ii-cormatrix-cor-tricuspid-ecm-valve-replacement-study 2026-03-22T08:40:40.733Z weekly 0.7 https://app.quri.ai/trials/NCT07106242/japan-post-market-adaptive-deep-brain-stimulation-adbs-study 2026-03-22T08:22:35.954Z weekly 0.7 https://app.quri.ai/trials/HIC#:2000038144/a-phase-ii-trial-of-durvalumab-with-gemcitabine-and-cisplati 2026-03-22T08:00:54.326Z weekly 0.7 https://app.quri.ai/trials/NCT07107334/a-pilot-study-to-estimate-early-clinical-efficacy-signals-of 2026-03-22T07:43:45.380Z weekly 0.7 https://app.quri.ai/trials/NCT05879926/a-phase-iii-adjuvant-trial-evaluating-the-addition-of-adjuva 2026-03-22T06:17:52.809Z weekly 0.7 https://app.quri.ai/trials/NCT03172026/maraviroc-to-augment-rehabilitation-outcomes-after-stroke 2026-03-21T02:49:35.218Z weekly 0.7 https://app.quri.ai/trials/NCT04807660/bacteriological-evaluation-of-children-with-otorrhea 2026-03-22T00:34:03.198Z weekly 0.7 https://app.quri.ai/trials/NCT04460313/nasopharyngeal-carriage-of-s-pneumoniae 2026-03-22T00:33:56.841Z weekly 0.7 https://app.quri.ai/trials/NCT07338110/french-achilles-tendon-surgery-cohort-study 2026-03-22T00:33:49.021Z weekly 0.7 https://app.quri.ai/trials/NCT06260345/communautary-pediatric-bacterial-infection-in-intensive-care 2026-03-22T00:33:29.932Z weekly 0.7 https://app.quri.ai/trials/NCT07481526/a-prospecitve-multicenter-observational-registry-study 2026-03-22T00:33:10.727Z weekly 0.7 https://app.quri.ai/trials/NCT07486752/bag3-dcm-natural-history-study 2026-03-23T00:32:38.221Z weekly 0.7 https://app.quri.ai/trials/NCT07485153/a-study-to-compare-two-different-sleep-tests-in-participants 2026-03-23T00:32:31.648Z weekly 0.7 https://app.quri.ai/trials/NCT07484971/study-of-the-epidemiological-clinical-diagnostic-and-therape 2026-03-23T00:32:31.040Z weekly 0.7 https://app.quri.ai/trials/NCT07484204/evaluate-pharmacokinetics-safety-and-tolerability-of-ax251-l 2026-03-23T00:32:25.935Z weekly 0.7 https://app.quri.ai/trials/NCT07484724/a-study-evaluating-the-safety-and-efficacy-of-js212-combinat 2026-03-26T00:34:04.904Z weekly 0.7 https://app.quri.ai/trials/NCT07485829/zimmer-biomet-ribfix-titan 2026-03-27T00:32:37.663Z weekly 0.7 https://app.quri.ai/trials/NCT07486713/olutasidenib-ddi-study-in-patients-with-idh1-mutation-positi 2026-03-23T00:32:13.200Z weekly 0.7 https://app.quri.ai/trials/NCT07486102/a-study-to-test-how-bi-3000202-is-taken-up-in-the-blood-of-p 2026-03-27T00:31:48.152Z weekly 0.7 https://app.quri.ai/trials/NCT07485504/safety-and-efficacy-of-dit101-in-relapsed-or-refractory-hema 2026-03-23T00:32:09.572Z weekly 0.7 https://app.quri.ai/trials/NCT07484230/a-phase-3-study-to-assess-the-efficacy-safety-and-tolerabili 2026-03-23T00:32:05.124Z weekly 0.7 https://app.quri.ai/trials/NCT07486089/dual-target-car-nk-cells-for-advanced-breast-cancer-her2-and 2026-03-23T00:32:04.179Z weekly 0.7 https://app.quri.ai/trials/NCT07484893/a-study-to-evaluate-the-safety-pk-and-immunogenicity-of-reco 2026-03-23T00:31:51.688Z weekly 0.7 https://app.quri.ai/trials/NCT07486453/bioequivalence-study-of-sacubitril-alisartan-amlodipine-tabl 2026-03-23T00:31:50.176Z weekly 0.7 https://app.quri.ai/trials/NCT07485205/establishing-normative-urodynamics-parameters-for-the-glean- 2026-03-23T00:31:33.947Z weekly 0.7 https://app.quri.ai/trials/NCT07485582/exploration-of-current-and-new-technologies-for-accuracy-of- 2026-03-23T00:31:32.448Z weekly 0.7 https://app.quri.ai/trials/NCT07486115/a-study-to-test-how-different-doses-of-bi-3814916-are-tolera 2026-04-03T00:33:35.206Z weekly 0.7 https://app.quri.ai/trials/NCT07484191/contralateral-claims-study-of-clareon-vivity-pro 2026-03-23T00:31:21.086Z weekly 0.7 https://app.quri.ai/trials/NCT07484269/pulse-registry-for-patients-receiving-lutetium-177lu-vipivot 2026-03-23T00:31:14.237Z weekly 0.7 https://app.quri.ai/trials/NCT07484217/clinical-assessment-of-response-in-the-treatment-of-depressi 2026-03-23T00:30:52.746Z weekly 0.7 https://app.quri.ai/trials/NCT07485595/a-study-of-the-effectiveness-and-safety-of-js1-1-01-tablet-i 2026-03-23T00:30:52.225Z weekly 0.7 https://app.quri.ai/trials/NCT07484139/h-n-neo-combat-xl-neoadjuvant-xl-092-zanzalintinib-and-pembr 2026-03-20T04:40:41.681Z weekly 0.7 https://app.quri.ai/trials/NCT07481955/chlorhexidine-and-or-metronidazole-plus-fb301-pre-treatment- 2026-03-23T00:31:50.763Z weekly 0.7 https://app.quri.ai/trials/NCT07482761/multiple-myeloma-t-4-14-ffpe-samples 2026-03-22T00:33:50.241Z weekly 0.7 https://app.quri.ai/trials/NCT07481877/portosystemic-shunt-associated-pulmonary-hypertension-multi- 2026-03-22T00:32:46.320Z weekly 0.7 https://app.quri.ai/trials/NCT07483554/ibi343-in-combination-therapy-for-advanced-malignant-solid-t 2026-03-22T00:33:08.127Z weekly 0.7 https://app.quri.ai/trials/NCT07483450/a-study-to-evaluate-the-efficacy-safety-pharmacokinetics-and 2026-03-22T00:32:54.190Z weekly 0.7 https://app.quri.ai/trials/NCT07483632/a-study-to-learn-about-the-safety-of-diroximel-fumarate-drf- 2026-03-22T00:33:24.328Z weekly 0.7 https://app.quri.ai/trials/NCT07483268/a-study-of-stapokibart-injection-in-patients-with-chronic-rh 2026-03-22T00:34:12.163Z weekly 0.7 https://app.quri.ai/trials/NCT02353377/oxinium-dh-total-hip-arthroplasty-pivotal-study 2026-03-22T00:34:17.902Z weekly 0.7 https://app.quri.ai/trials/NCT07482813/an-open-label-extension-safety-study-to-evaluate-sd-101-in-e 2026-03-22T00:34:11.492Z weekly 0.7 https://app.quri.ai/trials/NCT07482787/efficacy-and-safety-study-to-evaluate-sd-101-in-epidermolysi 2026-03-23T00:31:38.926Z weekly 0.7 https://app.quri.ai/trials/NCT07483827/a-clinical-trial-to-test-the-safety-tolerability-and-how-the 2026-03-22T00:33:31.463Z weekly 0.7 https://app.quri.ai/trials/NCT07322887/a-phase-2-study-to-assess-the-effects-of-sul-238-on-high-ene 2026-04-01T00:32:21.207Z weekly 0.7 https://app.quri.ai/trials/NCT07483671/efficacy-and-safety-study-of-bpr-101-capsules-in-combination 2026-03-22T00:34:31.569Z weekly 0.7 https://app.quri.ai/trials/NCT04971772/signature-study-dcb-legflow-vs-poba-in-fempop-arteries 2026-03-22T00:34:17.699Z weekly 0.7 https://app.quri.ai/trials/NCT07482423/xvie-to-treat-androgenetic-alopecia-aga 2026-03-22T00:33:15.542Z weekly 0.7 https://app.quri.ai/trials/NCT07481734/tesamorelin-for-reduction-of-liver-fat-in-adults-with-fatty- 2026-03-22T00:34:16.697Z weekly 0.7 https://app.quri.ai/trials/NCT07483437/a-study-of-hs-20136-2-in-healthy-participants 2026-03-22T00:33:15.137Z weekly 0.7 https://app.quri.ai/trials/NCT07484035/safety-and-efficacy-evaluation-of-an-extensively-hydrolyzed- 2026-03-22T00:33:50.008Z weekly 0.7 https://app.quri.ai/trials/NCT07483099/a-study-of-ly4395089-and-mirikizumab-ly3074828-given-togethe 2026-03-22T00:33:01.485Z weekly 0.7 https://app.quri.ai/trials/NCT07482657/a-phase-2-study-to-investigate-the-efficacy-and-safety-of-ze 2026-03-22T00:34:23.093Z weekly 0.7 https://app.quri.ai/trials/NCT07483684/a-clinical-study-to-evaluate-injection-tqb2102-for-the-treat 2026-03-22T00:32:47.640Z weekly 0.7 https://app.quri.ai/trials/NCT07481630/a-research-study-investigating-how-well-the-medicine-nnc0487 2026-03-22T00:34:36.221Z weekly 0.7 https://app.quri.ai/trials/NCT07481981/a-study-to-evaluate-the-efficacy-and-safety-of-once-daily-tr 2026-03-22T00:34:02.724Z weekly 0.7 https://app.quri.ai/trials/NCT07483346/iaso-782-in-systemic-lupus-erythematosus 2026-03-22T00:33:27.238Z weekly 0.7 https://app.quri.ai/trials/NCT07483645/effectiveness-and-acceptability-of-lisefex-liposomal-iron-wi 2026-03-22T00:34:04.837Z weekly 0.7 https://app.quri.ai/trials/NCT07482176/efficacy-and-safety-study-of-ixoberogene-soroparvovec-ixo-ve 2026-03-22T00:34:14.909Z weekly 0.7 https://app.quri.ai/trials/NCT07483541/identification-of-modifiable-sleep-related-factors-in-patien 2026-03-22T00:34:18.098Z weekly 0.7 https://app.quri.ai/trials/NCT07482644/efficacy-and-safety-of-an-essential-oil-based-product-system 2026-03-22T00:33:12.338Z weekly 0.7 https://app.quri.ai/trials/NCT07481708/a-clinical-study-of-the-effect-of-enlicitide-mk-0616-formula 2026-03-22T00:33:58.656Z weekly 0.7 https://app.quri.ai/trials/NCT07483970/a-phase-i-ii-study-of-jl19001-injection-alone-or-in-combinat 2026-03-22T00:33:13.328Z weekly 0.7 https://app.quri.ai/trials/NCT07484022/study-of-gb-4362-with-enfortumab-vedotin-and-pembrolizumab-f 2026-03-22T00:33:57.828Z weekly 0.7 https://app.quri.ai/trials/NCT07481890/feasibility-and-efficacy-of-the-emdr-toolbox-method-in-cance 2026-04-03T00:33:42.467Z weekly 0.7 https://app.quri.ai/trials/NCT07483567/ibi343-in-combination-with-sintilimab-and-sox-regimen-for-pe 2026-03-22T00:33:28.991Z weekly 0.7 https://app.quri.ai/trials/NCT07481747/efficacy-and-safety-of-tirzepatide-once-weekly-versus-placeb 2026-03-22T00:33:46.931Z weekly 0.7 https://app.quri.ai/trials/NCT07483073/a-master-protocol-iibd-a-study-of-multiple-drugs-in-adults-w 2026-03-22T00:33:42.608Z weekly 0.7 https://app.quri.ai/trials/NCT07482592/clinical-trial-of-tqb3205-capsule-in-subjects-with-advanced- 2026-03-22T00:34:05.054Z weekly 0.7 https://app.quri.ai/trials/NCT07484061/efficacy-and-safety-of-a-drinkable-nutraceutical-for-hair-lo 2026-03-26T00:34:16.580Z weekly 0.7 https://app.quri.ai/trials/NCT06282588/treatment-of-high-risk-prostate-cancer-guided-by-novel-diagn 2026-03-22T00:33:02.386Z weekly 0.7 https://app.quri.ai/trials/NCT07484178/impact-of-nurse-led-interventions-on-respiratory-outcomes-in 2026-03-19T17:04:40.820Z weekly 0.7 https://app.quri.ai/trials/NCT07480616/efficacy-of-indonesian-asthmatic-gymnastic-as-combine-pulmon 2026-03-19T03:27:35.571Z weekly 0.7 https://app.quri.ai/trials/NCT07408583/prenatal-stem-cell-transplant-for-fanconi-anemia 2026-03-19T02:12:34.560Z weekly 0.7 https://app.quri.ai/trials/NCT07474038/ai-supported-cognitive-rehabilitation-for-older-adults-with- 2026-03-23T00:32:37.358Z weekly 0.7 https://app.quri.ai/trials/NCT07473505/integrative-bilateral-cervical-sympathetic-blocks-for-trauma 2026-03-23T00:31:09.342Z weekly 0.7 https://app.quri.ai/trials/NCT07473362/hyperbaric-oxygen-therapy-for-post-traumatic-stress-disorder 2026-03-19T00:37:05.895Z weekly 0.7 https://app.quri.ai/trials/NCT07476131/psychiatric-care-and-education-for-adolescents-and-young-adu 2026-03-20T00:35:40.685Z weekly 0.7 https://app.quri.ai/trials/NCT07476339/reinitiation-of-antiretroviral-therapy-using-oral-bictegravi 2026-04-03T00:36:56.776Z weekly 0.7 https://app.quri.ai/trials/NCT07481383/a-first-in-human-study-to-evaluate-implantable-iontophoresis 2026-03-21T00:39:41.756Z weekly 0.7 https://app.quri.ai/trials/NCT07479862/a-study-of-sa030-injection-in-overweight-or-obese-participan 2026-03-21T00:38:54.824Z weekly 0.7 https://app.quri.ai/trials/NCT07480928/dual-targeting-car-nk-cells-targeting-mesothelin-msln-and-mu 2026-03-21T00:40:16.853Z weekly 0.7 https://app.quri.ai/trials/NCT07479043/to-evaluate-the-safety-and-potential-therapeutic-activity-of 2026-03-22T00:33:18.024Z weekly 0.7 https://app.quri.ai/trials/NCT07478926/flow-detection-in-open-and-closed-shunt-valve-periods 2026-03-21T00:39:10.156Z weekly 0.7 https://app.quri.ai/trials/NCT07480564/safety-and-preliminary-efficacy-of-tsha-102-gene-therapy-in- 2026-03-21T00:38:51.710Z weekly 0.7 https://app.quri.ai/trials/NCT07480824/to-evaluate-the-pharmacokinetics-and-safety-of-tq05105-table 2026-03-21T00:39:04.832Z weekly 0.7 https://app.quri.ai/trials/NCT07479615/a-study-to-evaluate-the-efficacy-and-safety-of-mg-k10-in-par 2026-03-21T00:40:07.853Z weekly 0.7 https://app.quri.ai/trials/NCT07481110/study-of-the-epidemiological-clinical-diagnostic-and-therape 2026-03-30T00:32:14.244Z weekly 0.7 https://app.quri.ai/trials/NCT07479745/study-to-assess-the-mass-balance-recovery-metabolite-profile 2026-04-03T00:34:35.519Z weekly 0.7 https://app.quri.ai/trials/NCT07480902/comparison-between-liquid-based-cytology-and-molecular-scree 2026-03-21T00:40:06.830Z weekly 0.7 https://app.quri.ai/trials/NCT07468877/this-clinical-trial-compares-two-phacoemulsification-systems 2026-03-21T00:38:38.201Z weekly 0.7 https://app.quri.ai/trials/NCT05689853/study-of-ak119-combined-with-ak112-in-patients-with-advanced 2026-03-21T00:38:55.172Z weekly 0.7 https://app.quri.ai/trials/NCT07478822/a-study-on-recombinant-botulinum-toxin-type-a-yy001-for-inje 2026-04-03T00:34:06.229Z weekly 0.7 https://app.quri.ai/trials/NCT05997121/safety-and-performance-of-the-hexanium-tlif-system-in-the-tr 2026-03-21T00:40:15.298Z weekly 0.7 https://app.quri.ai/trials/NCT07481487/outcomes-of-cataract-refractive-procedures 2026-03-21T00:38:45.761Z weekly 0.7 https://app.quri.ai/trials/NCT07480603/pilot-study-on-a-new-self-adjustable-glaucoma-drainage-devic 2026-03-21T00:39:58.669Z weekly 0.7 https://app.quri.ai/trials/NCT07480356/efficacy-and-safety-of-intravesical-tara-002-compared-with-i 2026-03-21T00:38:57.217Z weekly 0.7 https://app.quri.ai/trials/NCT07480343/5-year-postoperative-outcomes-of-patients-who-completed-the- 2026-04-03T00:34:23.335Z weekly 0.7 https://app.quri.ai/trials/NCT07480681/phase-i-clinical-study-to-evaluate-the-safety-tolerability-p 2026-03-21T00:39:13.305Z weekly 0.7 https://app.quri.ai/trials/NCT07479173/effects-of-p24-on-postprandial-aminoacidemia 2026-03-22T00:33:40.016Z weekly 0.7 https://app.quri.ai/trials/NCT07481084/iga-nephropathy-insights-from-treatment-experience-among-pat 2026-03-21T00:39:28.021Z weekly 0.7 https://app.quri.ai/trials/NCT07479797/study-evaluating-the-efficacy-of-kite-753-versus-axicabtagen 2026-04-03T00:34:33.953Z weekly 0.7 https://app.quri.ai/trials/NCT07481058/kc1036-in-combination-with-pd-1-antibody-and-platinum-based- 2026-03-23T00:32:43.378Z weekly 0.7 https://app.quri.ai/trials/NCT07480213/adaptive-phase-1-2-study-of-dual-target-car-nk-cells-in-rela 2026-03-21T00:39:09.002Z weekly 0.7 https://app.quri.ai/trials/NCT07480590/glow-gender-affirming-care-and-mental-health-a-longitudinal- 2026-03-21T00:39:00.727Z weekly 0.7 https://app.quri.ai/trials/NCT07479433/the-navigate-pci-registry-a-new-approach-to-view-ct-derived- 2026-03-26T00:33:48.446Z weekly 0.7 https://app.quri.ai/trials/NCT07479381/colorectal-lesion-evaluation-and-appropriate-resolution-clea 2026-03-27T00:32:56.440Z weekly 0.7 https://app.quri.ai/trials/NCT07480421/clinical-evaluation-of-neorepair-acellular-matrix-in-immedia 2026-03-23T00:32:45.141Z weekly 0.7 https://app.quri.ai/trials/NCT07480395/real-world-data-collection-of-the-gore-devices-when-used-in- 2026-03-21T00:40:14.418Z weekly 0.7 https://app.quri.ai/trials/NCT07480941/dual-targeting-car-nk-cells-for-recurrent-progressive-gliobl 2026-03-21T00:40:18.145Z weekly 0.7 https://app.quri.ai/trials/NCT07478991/azacytidine-venetoclax-plus-minus-quizartinib-for-first-line 2026-03-21T00:38:54.453Z weekly 0.7 https://app.quri.ai/trials/NCT07479485/mrg006a-combination-therapy-for-advanced-hepatocellular-carc 2026-03-21T00:38:43.685Z weekly 0.7 https://app.quri.ai/trials/NCT07479277/progel-platinum-for-air-leak-reduction-after-vats-lobectomy- 2026-03-21T00:38:45.313Z weekly 0.7 https://app.quri.ai/trials/NCT04213261/a-study-of-fcx-007-for-recessive-dystrophic-epidermolysis-bu 2026-03-21T00:39:09.186Z weekly 0.7 https://app.quri.ai/trials/NCT07480954/dual-targeting-car-nk-cells-for-recurrent-ovarian-cancer-msl 2026-03-21T00:40:07.077Z weekly 0.7 https://app.quri.ai/trials/NCT07479992/multicenter-study-for-the-validation-of-willem-ai-aortic-ste 2026-03-23T00:31:56.613Z weekly 0.7 https://app.quri.ai/trials/NCT03468556/a-randomized-double-blind-placebo-controlled-study-to-assess 2026-03-21T00:38:44.822Z weekly 0.7 https://app.quri.ai/trials/NCT07479095/low-glucose-high-fat-intake-dietary-regimen-as-a-tool-for-em 2026-03-23T00:31:20.847Z weekly 0.7 https://app.quri.ai/trials/NCT07481474/pilot-and-feasibility-study-of-intra-articular-anti-cd14-for 2026-03-21T00:39:28.416Z weekly 0.7 https://app.quri.ai/trials/NCT07479667/an-antibody-armored-dendritic-cell-in-patients-with-solid-tu 2026-03-21T00:40:01.365Z weekly 0.7 https://app.quri.ai/trials/NCT06155409/safety-and-performance-of-the-spinevision-hexanium-acif-in-t 2026-03-21T00:38:58.325Z weekly 0.7 https://app.quri.ai/trials/NCT07479472/a-prospective-observational-study-on-of-early-onset-gastroin 2026-03-21T00:38:52.255Z weekly 0.7 https://app.quri.ai/trials/NCT07481357/a-first-in-human-phase-i-iia-study-to-evaluate-da-3501-in-pa 2026-03-21T00:40:14.891Z weekly 0.7 https://app.quri.ai/trials/NCT06342765/safety-and-performance-of-the-spinevision-posterior-fixation 2026-03-21T00:39:39.231Z weekly 0.7 https://app.quri.ai/trials/NCT07480733/phase-ii-study-of-js212-js213-as-monotherapy-and-in-combinat 2026-03-28T00:34:36.008Z weekly 0.7 https://app.quri.ai/trials/NCT07478952/a-study-of-an-epstein-barr-virus-ebv-candidate-vaccine-mrna- 2026-03-27T00:31:56.647Z weekly 0.7 https://app.quri.ai/trials/NCT05727189/a-study-of-idazoxan-in-healthy-participants 2026-03-21T00:39:57.231Z weekly 0.7 https://app.quri.ai/trials/NCT07479576/a-comparative-phase-1-study-to-evaluate-the-pharmacokinetic- 2026-03-21T00:39:30.841Z weekly 0.7 https://app.quri.ai/trials/NCT07479641/a-bioequivalence-study-of-two-formulations-of-hrs-1893-table 2026-03-21T00:39:24.444Z weekly 0.7 https://app.quri.ai/trials/NCT04967287/myopiax-1-proof-of-concept-clinical-trial 2026-03-18T02:22:17.434Z weekly 0.7 https://app.quri.ai/trials/NCT07473531/chatbot-to-support-healthcare-professionals-experiencing-wor 2026-03-22T00:32:58.319Z weekly 0.7 https://app.quri.ai/trials/NCT07476963/evaluation-of-the-food-effecton-the-pharmacokinetics-of-fwd1 2026-03-20T00:36:21.307Z weekly 0.7 https://app.quri.ai/trials/NCT07477990/clinical-trial-to-evaluate-the-efficacy-and-safety-of-the-au 2026-04-03T00:34:40.497Z weekly 0.7 https://app.quri.ai/trials/NCT07475910/venous-thromboembolism-and-chronic-pain-after-major-limb-tra 2026-03-21T00:39:31.797Z weekly 0.7 https://app.quri.ai/trials/NCT07476170/real-world-treatment-pattern-and-clinical-outcome-with-influ 2026-04-03T00:32:37.675Z weekly 0.7 https://app.quri.ai/trials/NCT07477223/beef-versus-whey-protein-the-gut-showdown-self-experiment 2026-03-20T00:35:49.111Z weekly 0.7 https://app.quri.ai/trials/NCT07476586/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics 2026-03-20T00:35:53.810Z weekly 0.7 https://app.quri.ai/trials/NCT07476157/a-study-to-evaluate-the-safety-and-pharmacokinetics-of-ad-11 2026-03-20T00:35:37.316Z weekly 0.7 https://app.quri.ai/trials/NCT07477639/treatment-of-participants-with-primary-or-secondary-progress 2026-03-22T00:33:13.146Z weekly 0.7 https://app.quri.ai/trials/NCT07476105/geriatric-guided-care-versus-conventional-care-in-elderly-un 2026-03-20T00:35:38.125Z weekly 0.7 https://app.quri.ai/trials/NCT07476066/clinical-study-of-sys6055-injection-in-participants-with-rel 2026-03-20T00:35:25.260Z weekly 0.7 https://app.quri.ai/trials/NCT07477587/a-study-to-compare-the-pk-characteristics-safety-tolerabilit 2026-03-20T00:35:42.437Z weekly 0.7 https://app.quri.ai/trials/NCT07476326/pharmacokinetics-safety-and-immunogenicity-comparison-of-bma 2026-03-20T00:35:42.857Z weekly 0.7 https://app.quri.ai/trials/NCT07477275/combination-of-oral-and-topical-whitening-agents-for-reducin 2026-03-20T00:36:07.639Z weekly 0.7 https://app.quri.ai/trials/NCT07478744/a-phase-2a-efficacy-safety-tolerability-and-pk-study-of-syt- 2026-03-20T00:35:35.485Z weekly 0.7 https://app.quri.ai/trials/NCT07477236/myvitalc-sleep-and-everyday-headache-management 2026-03-20T00:36:07.434Z weekly 0.7 https://app.quri.ai/trials/NCT07477704/a-study-to-see-how-safe-and-effective-alirocumab-is-when-giv 2026-03-20T00:36:03.276Z weekly 0.7 https://app.quri.ai/trials/NCT07476313/validation-and-usability-study-of-the-sleepview-home-sleep-t 2026-03-20T00:35:56.583Z weekly 0.7 https://app.quri.ai/trials/NCT07477743/a-phase-ib-clinical-study-on-the-safety-and-efficacy-of-hc01 2026-03-20T00:35:28.122Z weekly 0.7 https://app.quri.ai/trials/NCT07477366/study-of-cd19-t-hank-and-nai-with-rituximab-in-participants- 2026-03-20T00:36:13.161Z weekly 0.7 https://app.quri.ai/trials/NCT07475806/a-study-to-find-out-if-enfortumab-vedotin-given-with-pembrol 2026-03-20T00:35:51.761Z weekly 0.7 https://app.quri.ai/trials/NCT05478512/front-line-venobi-combination-followed-by-ven-or-venzan-comb 2026-03-20T00:35:50.179Z weekly 0.7 https://app.quri.ai/trials/NCT07476144/nordic-spirit-pouch-nicotine-pharmacokinetics-abuse-liabilit 2026-03-20T00:36:23.019Z weekly 0.7 https://app.quri.ai/trials/NCT07477405/drug-coated-balloon-multicentric-registry-in-spain-and-portu 2026-03-20T00:36:25.745Z weekly 0.7 https://app.quri.ai/trials/NCT07476196/poland-italy-aortic-research-bridge-real-world-registry 2026-03-23T00:30:50.527Z weekly 0.7 https://app.quri.ai/trials/NCT07475897/negative-pressure-wound-therapy-as-a-predictor-of-persistent 2026-03-21T00:39:29.231Z weekly 0.7 https://app.quri.ai/trials/NCT07478471/observational-study-of-raxibacumab-in-sporadic-cases-of-syst 2026-03-20T00:36:10.424Z weekly 0.7 https://app.quri.ai/trials/NCT07478302/a-study-of-shr-2524-plus-bevacizumab-in-the-first-line-treat 2026-03-20T00:35:57.024Z weekly 0.7 https://app.quri.ai/trials/NCT05170815/clariance-erys-registry 2026-03-20T00:35:27.810Z weekly 0.7 https://app.quri.ai/trials/NCT07477691/immune-modulation-during-palynziq-treatment-in-adults-impala 2026-03-20T00:35:54.975Z weekly 0.7 https://app.quri.ai/trials/NCT07477054/a-post-approval-multicenter-study-to-assess-the-continued-sa 2026-03-20T00:35:55.730Z weekly 0.7 https://app.quri.ai/trials/NCT07476183/assessing-the-safety-tolerability-and-efficacy-of-apr-2020-i 2026-03-21T00:39:37.411Z weekly 0.7 https://app.quri.ai/trials/NCT07478549/safety-evaluation-of-the-hypersperm-sperm-preparation-proced 2026-03-20T00:36:02.520Z weekly 0.7 https://app.quri.ai/trials/NCT07476118/a-study-of-brenipatide-ly3537031-in-healthy-participants-wit 2026-03-20T00:35:50.964Z weekly 0.7 https://app.quri.ai/trials/NCT07476287/symbiotic-lung-14-a-study-to-learn-about-the-study-medicine- 2026-03-20T00:36:20.437Z weekly 0.7 https://app.quri.ai/trials/NCT07478497/30-day-insulin-balance-metabolic-health-optimization-protoco 2026-03-20T00:35:33.226Z weekly 0.7 https://app.quri.ai/trials/NCT07475871/tourniquet-exposure-and-risk-of-chronic-pain-after-severe-li 2026-03-21T00:39:58.069Z weekly 0.7 https://app.quri.ai/trials/NCT05740358/liver-cirrhosis-network-cohort-study 2026-03-17T02:10:44.481Z weekly 0.7 https://app.quri.ai/trials/NCT05832229/liver-cirrhosis-network-rosuvastatin-efficacy-and-safety-for 2026-03-17T02:10:42.416Z weekly 0.7 https://app.quri.ai/trials/NCT07472907/a-study-testing-the-safety-and-possible-benefits-of-an-ear-i 2026-03-19T00:36:00.052Z weekly 0.7 https://app.quri.ai/trials/NCT07473726/a-phase-i-clinical-study-to-evaluate-the-safety-tolerability 2026-03-19T00:37:06.813Z weekly 0.7 https://app.quri.ai/trials/NCT07473544/essential-oil-inhalation-and-acute-stress-response-in-health 2026-03-19T00:35:23.043Z weekly 0.7 https://app.quri.ai/trials/NCT07473921/supracrestal-socket-sheild 2026-03-19T00:35:55.422Z weekly 0.7 https://app.quri.ai/trials/NCT07473037/efficacy-of-a-combined-oral-and-topical-collagen-regimen-com 2026-03-19T00:35:08.246Z weekly 0.7 https://app.quri.ai/trials/NCT07474792/dose-ranging-study-of-orka-002-in-patients-with-moderate-to- 2026-03-19T00:36:41.020Z weekly 0.7 https://app.quri.ai/trials/NCT07473674/this-study-evaluates-skin-response-following-application-of- 2026-03-28T00:35:04.100Z weekly 0.7 https://app.quri.ai/trials/NCT07474467/safety-and-efficacy-of-autologous-adipose-derived-mesenchyma 2026-03-19T00:35:28.472Z weekly 0.7 https://app.quri.ai/trials/NCT07472491/a-phase-2-3-study-on-the-efficacy-and-safety-of-mangaciclano 2026-03-19T00:35:43.837Z weekly 0.7 https://app.quri.ai/trials/NCT07472517/dareon-lung-1-a-study-in-people-with-advanced-small-cell-lun 2026-04-03T00:37:57.765Z weekly 0.7 https://app.quri.ai/trials/NCT07474935/targeting-real-world-usage-in-stroke-treatment 2026-03-19T00:35:31.583Z weekly 0.7 https://app.quri.ai/trials/NCT07473778/implementation-study-of-lenacapavir-pre-exposure-prophylaxis 2026-03-19T00:35:30.983Z weekly 0.7 https://app.quri.ai/trials/NCT07052253/a-phase-ii-clinical-study-of-ak104-ak112-in-combination-with 2026-03-19T00:36:12.837Z weekly 0.7 https://app.quri.ai/trials/NCT07474636/efficacy-and-safety-study-of-hs-10542-for-iga-nephropathy 2026-03-19T00:35:37.421Z weekly 0.7 https://app.quri.ai/trials/NCT07472361/a-study-of-enx-104-in-healthy-participants 2026-03-19T00:35:28.886Z weekly 0.7 https://app.quri.ai/trials/NCT07473128/effect-of-trilaciclib-in-the-prevention-of-myelosupression-i 2026-03-19T00:35:59.664Z weekly 0.7 https://app.quri.ai/trials/NCT07474506/from-battlefield-to-recovery-continuous-regional-anaesthesia 2026-03-20T00:36:31.746Z weekly 0.7 https://app.quri.ai/trials/NCT07472023/regenerative-medicine-and-stem-cell-based-interventions-for- 2026-03-19T00:35:42.648Z weekly 0.7 https://app.quri.ai/trials/NCT07475338/effect-of-storytelling-on-questionnaire-completion-and-quali 2026-03-19T00:36:01.475Z weekly 0.7 https://app.quri.ai/trials/NCT07474051/long-term-follow-up-of-avencell-sponsored-car-t-cell-clinica 2026-03-19T00:37:13.779Z weekly 0.7 https://app.quri.ai/trials/NCT07473570/a-study-phase-i-of-gs3-007a-dry-suspension-in-healthy-chines 2026-03-19T00:37:16.280Z weekly 0.7 https://app.quri.ai/trials/NCT02997345/pprom-registry-preterm-premature-rupture-of-membranes 2026-03-19T00:36:17.391Z weekly 0.7 https://app.quri.ai/trials/NCT07472790/a-study-on-the-novel-oncolytic-virus-combined-with-pd-1-inhi 2026-03-19T00:35:44.816Z weekly 0.7 https://app.quri.ai/trials/NCT07473427/immunogenicity-and-safety-of-varicella-vaccine-live-in-healt 2026-03-19T00:36:25.323Z weekly 0.7 https://app.quri.ai/trials/NCT07475468/cp382-intermittent-catheter-ic-pro-panel-plan 2026-03-19T00:36:43.122Z weekly 0.7 https://app.quri.ai/trials/NCT07475559/jskn016hc-in-patients-with-advanced-or-metastatic-solid-mali 2026-03-19T00:35:43.470Z weekly 0.7 https://app.quri.ai/trials/NCT07473323/evaluation-of-mtx-439-in-healthy-adults-and-adults-with-diab 2026-03-19T00:35:57.060Z weekly 0.7 https://app.quri.ai/trials/NCT07473817/validation-of-different-methods-for-hepquant-duo-blood-sampl 2026-03-19T00:36:34.235Z weekly 0.7 https://app.quri.ai/trials/NCT07475000/second-dose-of-varicella-vaccine-in-healthy-children 2026-03-19T00:35:59.851Z weekly 0.7 https://app.quri.ai/trials/NCT07475455/filler-post-market-survey-fips 2026-03-19T00:37:07.064Z weekly 0.7 https://app.quri.ai/trials/NCT07475611/effectiveness-of-an-interactive-screen-in-the-rehabilitation 2026-03-19T00:36:43.964Z weekly 0.7 https://app.quri.ai/trials/NCT07472439/auryon-atherectomy-system-with-standard-balloon-angioplasty- 2026-03-19T00:35:38.627Z weekly 0.7 https://app.quri.ai/trials/NCT07474272/non-surgical-treatment-of-periodontitis-with-adjunctive-sodi 2026-03-20T00:36:18.649Z weekly 0.7 https://app.quri.ai/trials/NCT05230810/clinical-trial-of-alpelisb-and-tucatinib-in-patients-with-pi 2026-03-19T00:36:24.597Z weekly 0.7 https://app.quri.ai/trials/NCT07472647/sys6090-combination-therapy-in-advanced-lung-cancer 2026-03-19T00:35:23.471Z weekly 0.7 https://app.quri.ai/trials/NCT07474649/a-study-of-bempedoic-acid-ezetimibe-high-intensity-statin-in 2026-03-22T00:34:30.964Z weekly 0.7 https://app.quri.ai/trials/NCT07475715/efficacy-and-safety-of-sublingual-immunotherapy-for-allergic 2026-03-19T00:35:52.387Z weekly 0.7 https://app.quri.ai/trials/NCT07473700/study-of-tx000045-in-participants-with-pulmonary-hypertensio 2026-03-19T00:36:09.365Z weekly 0.7 https://app.quri.ai/trials/NCT07475572/a-randomized-double-blind-pharmacokinetic-similarity-study-t 2026-03-19T00:36:10.971Z weekly 0.7 https://app.quri.ai/trials/NCT07474727/a-phase-ii-study-of-amt-676-combination-therapies-in-advance 2026-03-19T00:35:59.481Z weekly 0.7 https://app.quri.ai/trials/NCT07473960/ibi306-monotherapy-in-non-familial-hypercholesterolemia-and- 2026-03-19T00:35:56.470Z weekly 0.7 https://app.quri.ai/trials/NCT07473154/controlling-hyperactive-immunity-with-long-lived-lymphocytes 2026-03-19T00:35:13.531Z weekly 0.7 https://app.quri.ai/trials/NCT07473947/performance-and-safety-follow-up-of-bioabsorbable-headless-i 2026-03-21T00:38:40.026Z weekly 0.7 https://app.quri.ai/trials/NCT07472725/a-study-comparing-safety-and-efficacy-of-shr-3167-fixed-dose 2026-03-19T00:35:22.527Z weekly 0.7 https://app.quri.ai/trials/NCT07473167/study-of-safety-and-efficacy-of-tc011-in-the-relapsed-refrac 2026-03-19T00:35:29.824Z weekly 0.7 https://app.quri.ai/trials/NCT07475546/combination-gerotherapeutic-interventions-for-healthspan-imp 2026-03-19T00:35:10.943Z weekly 0.7 https://app.quri.ai/trials/NCT07473622/outcome-research-in-bowel-irrigation-techniques-for-the-trea 2026-03-19T00:35:41.288Z weekly 0.7 https://app.quri.ai/trials/NCT07473661/human-repeat-insult-patch-test-to-evaluate-skin-irritation-a 2026-03-30T00:32:18.288Z weekly 0.7 https://app.quri.ai/trials/NCT07473843/study-of-zodasiran-in-adolescent-participants-with-homozygou 2026-03-23T00:31:36.896Z weekly 0.7 https://app.quri.ai/trials/NCT07473973/energy-2-evaluation-of-the-efficacy-and-safety-of-inz-701-in 2026-03-21T00:38:52.647Z weekly 0.7 https://app.quri.ai/trials/NCT07462455/a-multicenter-open-label-multiple-dose-escalation-phase-b-cl 2026-03-15T10:47:11.526Z weekly 0.7 https://app.quri.ai/trials/IRAKLIA/iraklia-phase-3-study-of-sarclisa-in-multiple-myeloma 2026-03-15T10:44:25.522Z weekly 0.7 https://app.quri.ai/trials/NCT07464665/comparing-dual-mobility-cups-versus-unipolar-cups-for-unsele 2026-03-14T00:37:22.348Z weekly 0.7 https://app.quri.ai/trials/NCT07466316/a-study-comparing-higher-dose-chemotherapy-over-a-shorter-am 2026-03-15T00:34:04.022Z weekly 0.7 https://app.quri.ai/trials/NCT07470762/study-of-safety-and-efficacy-of-hs-10542-in-patients-with-pa 2026-03-16T00:32:51.902Z weekly 0.7 https://app.quri.ai/trials/NCT07471932/a-study-of-lad106-in-healthy-adult-participants 2026-03-16T00:32:48.200Z weekly 0.7 https://app.quri.ai/trials/NCT07469800/efficacy-and-safety-of-ibi362-in-hypertensive-patients-with- 2026-03-17T17:08:07.263Z weekly 0.7 https://app.quri.ai/trials/NCT07471750/acquisition-and-clinical-image-evaluation-of-fujifilm-s-high 2026-03-19T00:36:39.958Z weekly 0.7 https://app.quri.ai/trials/NCT06171113/a-study-to-investigate-the-safety-of-gsk4024484-in-healthy-a 2026-04-03T00:34:33.520Z weekly 0.7 https://app.quri.ai/trials/NCT07470853/a-study-of-muc16-directed-antibody-drug-conjugate-hwk-016-in 2026-03-16T00:32:42.908Z weekly 0.7 https://app.quri.ai/trials/NCT07471308/p-wave-duration-and-local-potential-as-predictors-of-af-recu 2026-04-03T00:33:10.487Z weekly 0.7 https://app.quri.ai/trials/NCT07344168/endoart-implantation-in-subjects-with-chronic-corneal-edema- 2026-03-16T00:32:35.686Z weekly 0.7 https://app.quri.ai/trials/NCT04246463/terumo-aortic-global-endovascular-registry 2026-03-16T00:32:33.229Z weekly 0.7 https://app.quri.ai/trials/NCT07470411/safety-and-feasibility-of-the-macs-in-surgical-procedures-a- 2026-03-16T00:32:33.046Z weekly 0.7 https://app.quri.ai/trials/NCT07471880/a-phase-ii-trial-of-rab001-llp2a-alendronate-for-steroid-ind 2026-03-27T00:32:12.450Z weekly 0.7 https://app.quri.ai/trials/NCT07469891/a-phase-1-study-of-prt12396-in-participants-with-select-myel 2026-04-03T00:37:43.233Z weekly 0.7 https://app.quri.ai/trials/NCT07469917/safety-planning-intervention-in-swedish-healthcare-a-multisi 2026-03-16T00:32:29.526Z weekly 0.7 https://app.quri.ai/trials/NCT07470983/a-phase-ii-clinical-study-on-the-efficacy-and-safety-of-hrs- 2026-04-03T00:34:28.649Z weekly 0.7 https://app.quri.ai/trials/NCT07471217/c-hydronidone-mass-balance-study 2026-03-16T00:32:22.503Z weekly 0.7 https://app.quri.ai/trials/NCT07471048/a-study-to-evaluate-the-impact-of-a-magnolia-officinalis-die 2026-03-16T00:32:15.465Z weekly 0.7 https://app.quri.ai/trials/NCT07469085/a-clinical-trial-to-evaluate-the-safety-tolerability-pharmac 2026-03-22T00:33:47.441Z weekly 0.7 https://app.quri.ai/trials/NCT07468851/a-study-of-hs-10566-in-patients-with-high-risk-non-muscle-in 2026-03-16T00:32:11.076Z weekly 0.7 https://app.quri.ai/trials/NCT07470177/a-study-to-investigate-the-effects-of-jmkx003142-on-qtc-inte 2026-03-16T00:32:04.596Z weekly 0.7 https://app.quri.ai/trials/NCT07470645/effects-of-probiotic-supplementation-on-stress-and-anxiety-i 2026-03-20T00:35:38.392Z weekly 0.7 https://app.quri.ai/trials/NCT07469215/behavioral-parent-training-with-and-without-ai-support-for-c 2026-03-16T00:32:00.418Z weekly 0.7 https://app.quri.ai/trials/NCT07471789/safety-and-efficacy-of-gya01-cart84-in-relapsed-refractory-r 2026-03-16T00:32:00.206Z weekly 0.7 https://app.quri.ai/trials/NCT07471230/evaluation-of-neuroinduced-mesenchymal-stem-cells-and-mesenc 2026-03-16T00:31:48.271Z weekly 0.7 https://app.quri.ai/trials/NCT07469579/alps-single-chamber-new-device-study 2026-03-21T00:38:38.859Z weekly 0.7 https://app.quri.ai/trials/NCT07470879/a-study-of-how-the-medicine-called-etrasimod-works-in-childr 2026-03-16T00:31:46.455Z weekly 0.7 https://app.quri.ai/trials/NCT07471659/effect-of-daily-humiome-post-lb-intake-on-wellbeing-in-older 2026-03-16T00:31:46.253Z weekly 0.7 https://app.quri.ai/trials/NCT07469774/bc3195-in-combination-with-pembrolizumab-in-participants-wit 2026-03-16T00:31:45.878Z weekly 0.7 https://app.quri.ai/trials/NCT07470125/bioequivalence-be-study-between-yhp2511-and-yhp2511a-in-heal 2026-03-16T00:31:43.854Z weekly 0.7 https://app.quri.ai/trials/NCT05555459/performance-and-safety-evaluation-of-inion-compresson-screw- 2026-03-16T00:31:39.920Z weekly 0.7 https://app.quri.ai/trials/NCT07469709/a-study-of-biological-genetic-and-constitutional-factors-and 2026-03-16T00:31:33.161Z weekly 0.7 https://app.quri.ai/trials/NCT07470827/evaluation-of-waymed-endo-cl-cs-for-automated-detection-and- 2026-03-16T00:31:31.222Z weekly 0.7 https://app.quri.ai/trials/NCT07471477/bacterial-reduction-for-a-manual-toothbrush-with-a-360-degre 2026-03-21T00:39:38.312Z weekly 0.7 https://app.quri.ai/trials/NCT07471841/olutasidenib-in-relapsed-idh1-mutated-aml-patients-who-have- 2026-03-16T00:31:28.177Z weekly 0.7 https://app.quri.ai/trials/NCT07471295/toric-performance-and-constant-evaluation 2026-03-16T00:31:13.628Z weekly 0.7 https://app.quri.ai/trials/NCT07470463/evaluation-of-one-shot-vision-differential-diagnosis-osvde-a 2026-03-28T00:34:49.628Z weekly 0.7 https://app.quri.ai/trials/NCT07471490/specimen-and-data-collection-for-a-novel-biomarker-combinati 2026-03-16T00:31:06.203Z weekly 0.7 https://app.quri.ai/trials/NCT07469202/cytalux-dose-extension-study 2026-03-16T00:31:04.973Z weekly 0.7 https://app.quri.ai/trials/NCT07469527/effects-of-feel-free-classic-tonic-on-stress-and-pharmacokin 2026-04-03T00:32:33.650Z weekly 0.7 https://app.quri.ai/trials/NCT07470788/fih-ita-study-vesalius-tmvr-system-for-symptomatic-degenerat 2026-03-16T00:30:56.767Z weekly 0.7 https://app.quri.ai/trials/NCT07470866/a-study-to-compare-the-amount-of-two-forms-of-tafamidis-in-t 2026-03-22T00:34:01.802Z weekly 0.7 https://app.quri.ai/trials/NCT07465887/ultrasound-guided-rhomboid-intercostal-block-versus-thoracic 2026-03-23T00:31:05.329Z weekly 0.7 https://app.quri.ai/trials/NCT07463703/accelerated-transcranial-magnetic-stimulation-for-post-traum 2026-03-14T00:36:00.957Z weekly 0.7 https://app.quri.ai/trials/NCT07466264/contactless-human-machine-interface-based-on-magnetometers-f 2026-03-15T00:33:31.739Z weekly 0.7 https://app.quri.ai/trials/NCT07465848/prospective-multicentre-study-for-the-application-of-telomer 2026-03-15T00:34:53.752Z weekly 0.7 https://app.quri.ai/trials/NCT07465965/a-clinical-study-of-semaglutide-nasal-spray-in-overweight-or 2026-03-15T00:33:24.616Z weekly 0.7 https://app.quri.ai/trials/NCT07465666/a-real-world-study-of-the-effectiveness-of-angiotensin-recep 2026-03-15T00:33:46.351Z weekly 0.7 https://app.quri.ai/trials/NCT07467317/bv-chp-real-life-and-biological-evidences-in-patients-with-s 2026-04-02T00:34:55.747Z weekly 0.7 https://app.quri.ai/trials/NCT07467629/qls5212-for-participants-with-advanced-solid-tumors 2026-03-15T00:35:07.885Z weekly 0.7 https://app.quri.ai/trials/NCT07465705/clinical-trial-on-bowel-preparation-comparing-mannitol-100g- 2026-03-16T00:30:56.097Z weekly 0.7 https://app.quri.ai/trials/NCT07467733/evaluation-of-the-safety-and-preliminary-efficacy-of-neuroin 2026-03-15T00:33:58.984Z weekly 0.7 https://app.quri.ai/trials/NCT07466940/a-clinical-study-to-evaluate-sm17-in-healthy-participants 2026-03-19T00:36:13.794Z weekly 0.7 https://app.quri.ai/trials/NCT07468500/real-world-adherence-of-pcsk9-targeted-therapy 2026-03-23T00:32:39.099Z weekly 0.7 https://app.quri.ai/trials/NCT07465679/a-real-world-study-of-clinical-treatment-guidelines-for-pati 2026-03-15T00:34:49.406Z weekly 0.7 https://app.quri.ai/trials/NCT07465757/a-study-of-alisertib-and-paclitaxel-in-patients-with-small-c 2026-03-15T00:34:31.760Z weekly 0.7 https://app.quri.ai/trials/NCT06322628/a-phase-2-clinical-trial-to-evaluate-the-efficacy-and-safety 2026-03-15T00:34:24.520Z weekly 0.7 https://app.quri.ai/trials/NCT07466745/autus-valve-continued-access-study-cas 2026-03-15T00:34:19.217Z weekly 0.7 https://app.quri.ai/trials/NCT07467447/effect-of-ly3437943-versus-placebo-in-participants-who-have- 2026-03-15T00:33:27.550Z weekly 0.7 https://app.quri.ai/trials/NCT07465835/a-study-of-ela026-in-participants-with-relapsed-refractory-r 2026-03-15T00:33:58.120Z weekly 0.7 https://app.quri.ai/trials/NCT07466160/a-phase-ib-ii-study-of-7mw3711-combined-with-js207-in-advanc 2026-03-15T00:34:53.971Z weekly 0.7 https://app.quri.ai/trials/NCT07465718/trientine-tetrahydrochloride-administered-once-a-day-for-the 2026-03-15T00:34:01.493Z weekly 0.7 https://app.quri.ai/trials/NCT07468396/a-phase-i-clinical-study-of-glr2037-in-patients-with-advance 2026-03-15T00:34:35.308Z weekly 0.7 https://app.quri.ai/trials/NCT07466667/to-determine-the-effect-of-phaseolean-on-glycemic-response-t 2026-03-28T00:34:33.641Z weekly 0.7 https://app.quri.ai/trials/NCT07466550/a-study-to-assess-how-intravenous-and-subcutaneous-administr 2026-03-15T00:34:14.612Z weekly 0.7 https://app.quri.ai/trials/NCT07467668/infusing-needed-iron-to-target-insufficiency-in-adults-treat 2026-03-15T00:34:13.283Z weekly 0.7 https://app.quri.ai/trials/NCT07468071/rollover-study-for-participants-who-have-been-treated-with-a 2026-04-03T00:34:02.203Z weekly 0.7 https://app.quri.ai/trials/NCT07468266/nasal-airflow-in-post-operative-patients 2026-03-15T00:33:48.324Z weekly 0.7 https://app.quri.ai/trials/NCT07468409/oryom-robotic-surgical-system-in-cataract-surgery 2026-03-15T00:34:37.233Z weekly 0.7 https://app.quri.ai/trials/NCT07467239/a-prospective-clinical-investigation-of-dmfi300-for-treating 2026-03-15T00:34:33.128Z weekly 0.7 https://app.quri.ai/trials/NCT07467564/the-impact-of-dupilumab-treatment-on-anxiety-and-depression- 2026-03-15T00:34:52.203Z weekly 0.7 https://app.quri.ai/trials/NCT07467863/dual-target-car-nk-cells-directed-against-msln-egfr-or-her2- 2026-03-15T00:33:59.541Z weekly 0.7 https://app.quri.ai/trials/NCT07467252/aiph-tb-ai-optimised-pyrazinamide-hydroxychloroquine-vs-stan 2026-03-15T00:34:22.819Z weekly 0.7 https://app.quri.ai/trials/NCT07467993/study-to-assess-the-safety-tolerability-and-treatment-respon 2026-03-23T00:32:37.559Z weekly 0.7 https://app.quri.ai/trials/NCT07466602/cfdna-methylation-for-liver-cancer-recurrence-detection 2026-03-26T00:34:40.351Z weekly 0.7 https://app.quri.ai/trials/NCT07466017/a-study-of-cs060380-tablets-in-patients-with-mash-and-obesit 2026-03-15T00:34:18.718Z weekly 0.7 https://app.quri.ai/trials/NCT07468617/repeat-treatment-with-metered-cryospray-in-patients-with-chr 2026-03-21T00:38:42.534Z weekly 0.7 https://app.quri.ai/trials/NCT07465653/a-safety-and-tolerability-study-of-hjb647-in-heart-failure-p 2026-03-15T00:35:08.362Z weekly 0.7 https://app.quri.ai/trials/NCT07468214/digitizing-and-automating-the-diagnostic-psychiatric-assessm 2026-03-15T00:34:34.559Z weekly 0.7 https://app.quri.ai/trials/NCT07468370/real-time-craniotomy-planning-using-mixed-reality 2026-03-15T00:34:32.162Z weekly 0.7 https://app.quri.ai/trials/FASCINATE-2/phase-2b-fascinate-2-clinical-trial-of-denifanstat-in-mash 2026-03-12T02:06:18.295Z weekly 0.7 https://app.quri.ai/trials/IRCT20191022045185N1/the-efficacy-and-safety-of-influenza-vaccine-in-pemphigus-in 2026-03-12T02:04:36.531Z weekly 0.7 https://app.quri.ai/trials/NCT07463144/evaluation-of-a-mobile-wellness-application-and-wearable-fit 2026-03-14T00:36:16.390Z weekly 0.7 https://app.quri.ai/trials/NCT07463846/a-study-to-evaluate-aln-2232-in-participants-with-obesity 2026-03-14T00:36:45.660Z weekly 0.7 https://app.quri.ai/trials/NCT07459790/the-study-is-being-conducted-to-find-a-new-treatment-for-pat 2026-03-13T00:34:54.131Z weekly 0.7 https://app.quri.ai/trials/NCT07463079/clinical-evaluation-of-a-soothing-moisturizing-lotion-in-ind 2026-03-19T00:35:36.925Z weekly 0.7 https://app.quri.ai/trials/NCT07464730/postoperative-high-flow-nasal-oxygenation-after-high-risk-su 2026-03-14T00:37:18.548Z weekly 0.7 https://app.quri.ai/trials/NCT07464704/infrasensor-for-early-detection-of-a-high-grade-obstructive- 2026-03-30T00:32:03.449Z weekly 0.7 https://app.quri.ai/trials/NCT07459868/self-care-program-and-burnout-prevention-in-first-year-medic 2026-03-14T00:36:04.555Z weekly 0.7 https://app.quri.ai/trials/NCT07463781/neurocognitive-assessment-in-adults-undergoing-cd19-targeted 2026-03-16T00:31:15.953Z weekly 0.7 https://app.quri.ai/trials/NCT07464327/a-phase-iii-study-of-hs-20093-injection-combined-with-adebre 2026-03-14T00:36:08.125Z weekly 0.7 https://app.quri.ai/trials/NCT07459647/a-long-term-open-label-study-of-ml-007c-ma-in-adults-with-sc 2026-03-13T00:34:50.515Z weekly 0.7 https://app.quri.ai/trials/NCT07464314/a-study-on-the-safety-and-immune-response-of-investigational 2026-03-30T00:33:02.545Z weekly 0.7 https://app.quri.ai/trials/NCT07463196/a-study-investigating-the-safety-absorption-elimination-and- 2026-03-14T00:37:21.735Z weekly 0.7 https://app.quri.ai/trials/NCT07464587/evaluation-of-the-inhaled-tqc3721-suspension-in-patients-wit 2026-03-14T00:36:08.916Z weekly 0.7 https://app.quri.ai/trials/NCT07464145/a-study-of-ndv-01-sustained-release-gemcitabine-docetaxel-in 2026-03-14T00:36:03.939Z weekly 0.7 https://app.quri.ai/trials/NCT07464847/pc400-coils-for-treatment-of-intracranial-aneurysms 2026-03-14T00:37:00.127Z weekly 0.7 https://app.quri.ai/trials/NCT07465263/a-study-to-evaluate-the-syh2053-injection-in-patients-with-h 2026-03-22T00:34:21.572Z weekly 0.7 https://app.quri.ai/trials/NCT07465120/a-multicenter-randomized-double-blind-placebo-controlled-pha 2026-03-14T00:36:20.976Z weekly 0.7 https://app.quri.ai/trials/NCT07463183/a-study-to-evaluate-efficacy-and-safety-of-mk-8690-in-partic 2026-04-02T00:35:27.713Z weekly 0.7 https://app.quri.ai/trials/NCT07465029/a-study-of-incidence-treatment-patterns-and-outcomes-in-tran 2026-03-14T00:36:28.911Z weekly 0.7 https://app.quri.ai/trials/NCT07464353/xdot-access-management-system-early-feasibility-study 2026-03-14T00:36:16.221Z weekly 0.7 https://app.quri.ai/trials/NCT07463768/study-evaluating-the-efficacy-and-safety-of-the-addition-of- 2026-03-14T00:37:14.607Z weekly 0.7 https://app.quri.ai/trials/NCT07463521/a-study-to-evaluate-the-efficacy-and-safety-of-rozanolixizum 2026-03-20T00:36:20.224Z weekly 0.7 https://app.quri.ai/trials/NCT07464925/a-phase-1-safety-and-dose-finding-study-of-glix1-in-adults-w 2026-03-23T00:30:53.257Z weekly 0.7 https://app.quri.ai/trials/NCT07465224/a-study-to-evaluate-aln-4324-on-insulin-sensitivity-in-adult 2026-03-25T14:50:48.913Z weekly 0.7 https://app.quri.ai/trials/NCT07465172/gdf-15-and-its-relationship-with-treatment-related-adverse-e 2026-03-14T00:36:09.886Z weekly 0.7 https://app.quri.ai/trials/NCT07464444/an-observational-study-of-medical-device-hald-heart-and-lung 2026-03-14T00:36:50.956Z weekly 0.7 https://app.quri.ai/trials/NCT07464873/reliability-validity-and-acceptability-of-a-novel-visual-sca 2026-03-14T00:36:30.775Z weekly 0.7 https://app.quri.ai/trials/NCT07465289/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-roz 2026-03-14T00:36:57.590Z weekly 0.7 https://app.quri.ai/trials/NCT07465198/autologous-stem-cell-therapy-in-patients-with-multiple-syste 2026-03-14T00:36:47.699Z weekly 0.7 https://app.quri.ai/trials/NCT07464275/performance-assessment-of-the-magenta-blast-algorithm-for-em 2026-03-15T00:33:30.440Z weekly 0.7 https://app.quri.ai/trials/NCT07463261/results-of-low-anterior-resections-with-or-without-preventiv 2026-03-14T00:36:28.242Z weekly 0.7 https://app.quri.ai/trials/NCT07463573/qlc5508-vs-chemotherapy-in-pretreated-advanced-or-metastatic 2026-03-14T00:37:21.298Z weekly 0.7 https://app.quri.ai/trials/NCT07463716/the-effect-of-home-and-hospital-mask-designs-on-respiratory- 2026-03-14T00:36:19.131Z weekly 0.7 https://app.quri.ai/trials/NCT05987358/a-clinical-study-of-tqb3454-tablets-in-the-treatment-of-adva 2026-03-14T00:36:09.102Z weekly 0.7 https://app.quri.ai/trials/NCT07462234/continuous-n-of-1-computational-feasibility-study-of-a-whole 2026-03-13T00:34:24.703Z weekly 0.7 https://app.quri.ai/trials/NCT07461155/stingless-bee-honey-mouth-rinse-on-gingivitis 2026-03-13T00:35:19.412Z weekly 0.7 https://app.quri.ai/trials/NCT07459634/a-study-of-lurbinectedin-in-combination-with-durvalumab-for- 2026-03-13T00:34:31.159Z weekly 0.7 https://app.quri.ai/trials/NCT07463053/mass-balance-and-absolute-bioavailability-study-of-jmkx00314 2026-03-13T00:34:42.479Z weekly 0.7 https://app.quri.ai/trials/NCT07462780/a-phase-i-clinical-trial-to-evaluate-cms-d017-following-sing 2026-03-13T00:34:43.634Z weekly 0.7 https://app.quri.ai/trials/NCT07462481/probiotic-improve-constipation 2026-03-13T00:34:23.826Z weekly 0.7 https://app.quri.ai/trials/NCT07462143/a-phase-clinical-trial-of-rc148-plus-chemotherapy-as-1l-ther 2026-03-13T00:35:06.184Z weekly 0.7 https://app.quri.ai/trials/NCT07462377/a-phase-1-study-of-epi-326-in-egfr-mutant-nsclc-and-hnscc 2026-03-28T00:34:39.821Z weekly 0.7 https://app.quri.ai/trials/NCT07462923/hs-20093-in-patients-with-advanced-gastric-and-gastroesophag 2026-03-13T00:35:18.342Z weekly 0.7 https://app.quri.ai/trials/NCT07461935/alps-single-chamber-new-device 2026-03-13T00:34:28.056Z weekly 0.7 https://app.quri.ai/trials/NCT07459712/pharmacokinetics-and-pharmacodynamics-of-ths-with-levia-comp 2026-03-13T00:35:03.555Z weekly 0.7 https://app.quri.ai/trials/NCT07460206/pembrolizumab-plus-lenvatinib-in-recurrent-ccrcc-patients-fa 2026-03-13T00:34:38.782Z weekly 0.7 https://app.quri.ai/trials/NCT07462130/an-efficacy-and-safety-study-of-ntb003-in-participants-with- 2026-03-13T00:35:03.873Z weekly 0.7 https://app.quri.ai/trials/NCT07461259/safety-and-feasibility-of-twiice-rise-phase-2 2026-03-13T00:34:49.975Z weekly 0.7 https://app.quri.ai/trials/NCT07460245/maintenance-avelumab-after-second-line-platinum-based-chemot 2026-03-13T00:34:41.311Z weekly 0.7 https://app.quri.ai/trials/NCT07462533/assess-efficacy-of-a-nanodiamond-periprocedural-skin-care-re 2026-03-13T00:34:52.091Z weekly 0.7 https://app.quri.ai/trials/NCT07462442/study-of-qls5308-in-patients-with-advanced-solid-tumors 2026-03-13T00:35:10.582Z weekly 0.7 https://app.quri.ai/trials/NCT05781048/a-phase-i-clinical-study-of-the-safety-tolerability-pharmaco 2026-03-13T00:34:51.895Z weekly 0.7 https://app.quri.ai/trials/NCT07462650/dual-target-car-nk-cells-for-biomarker-selected-advanced-col 2026-03-13T00:34:57.821Z weekly 0.7 https://app.quri.ai/trials/NCT07459751/a-global-phase-ii-iii-clinical-study-to-evaluate-the-efficac 2026-03-13T00:34:49.337Z weekly 0.7 https://app.quri.ai/trials/NCT07459660/an-open-label-study-of-ml-007c-ma-in-adults-with-alzheimer-s 2026-03-13T00:34:38.020Z weekly 0.7 https://app.quri.ai/trials/NCT07462494/probiotic-intervention-in-constipation 2026-04-03T00:32:30.645Z weekly 0.7 https://app.quri.ai/trials/NCT07460323/study-of-tre-seals-on-early-post-operative-subjects 2026-03-13T00:34:39.164Z weekly 0.7 https://app.quri.ai/trials/NCT07461220/safety-and-tolerability-of-irl757-in-participants-with-parki 2026-03-13T00:34:57.630Z weekly 0.7 https://app.quri.ai/trials/NCT07459699/effects-of-probiotics-on-the-gut-brain-axis-in-children 2026-03-13T00:35:08.398Z weekly 0.7 https://app.quri.ai/trials/NCT07459738/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-hlx4 2026-03-13T00:34:28.240Z weekly 0.7 https://app.quri.ai/trials/NCT07459829/study-of-cu06-1004-in-patients-with-daibetic-macular-edema 2026-03-13T00:34:40.914Z weekly 0.7 https://app.quri.ai/trials/NCT07462910/diaphragmatic-evaluation-by-fluoroscopy-to-identify-phrenic- 2026-03-13T00:35:09.896Z weekly 0.7 https://app.quri.ai/trials/NCT07461493/the-cancer-stage-shifting-initiative-registry-and-bioreposit 2026-03-13T00:35:17.625Z weekly 0.7 https://app.quri.ai/trials/NCT07462819/a-study-to-evaluate-the-safety-and-tolerability-of-intraveno 2026-03-22T00:32:53.533Z weekly 0.7 https://app.quri.ai/trials/NCT07461454/yl202-versus-treatment-of-physician-s-choice-in-patients-wit 2026-03-13T00:35:22.049Z weekly 0.7 https://app.quri.ai/trials/NCT07460375/a-study-to-evaluate-claudin-18-2-directed-adc-lcb02a-in-adva 2026-03-13T00:35:09.634Z weekly 0.7 https://app.quri.ai/trials/NCT07462897/evaluation-of-the-effectiveness-of-a-new-generation-of-myopi 2026-03-13T00:34:40.008Z weekly 0.7 https://app.quri.ai/trials/NCT07462312/digital-biofeedback-for-combat-veterans-diagnosed-with-ptsd 2026-03-13T00:34:35.187Z weekly 0.7 https://app.quri.ai/trials/NCT07460284/a-mass-balance-study-of-14c-ray1225-injection-in-healthy-chi 2026-03-13T00:34:36.659Z weekly 0.7 https://app.quri.ai/trials/NCT07460986/a-phase-ib-ii-study-to-evaluate-safety-and-efficacy-of-bexma 2026-03-13T00:34:50.317Z weekly 0.7 https://app.quri.ai/trials/NCT07459686/an-observational-study-to-learn-about-velsipity-after-long-t 2026-03-13T00:34:52.496Z weekly 0.7 https://app.quri.ai/trials/NCT07462468/a-phase-1-clinical-study-to-evaluate-the-safety-and-efficacy 2026-03-16T00:32:13.249Z weekly 0.7 https://app.quri.ai/trials/NCT07461649/pharmacokinetic-study-of-eicosapentaenoic-acid-epa-and-calci 2026-03-19T00:37:08.683Z weekly 0.7 https://app.quri.ai/trials/NCT07456865/post-approval-effectiveness-and-durability-evaluation-of-the 2026-03-22T00:34:32.618Z weekly 0.7 https://app.quri.ai/trials/NCT07457151/danicopan-pms-in-korea 2026-03-12T00:34:09.339Z weekly 0.7 https://app.quri.ai/trials/NCT07457294/1-clascoterone-cream-for-the-treatment-acne-vulgaris 2026-03-12T00:35:05.423Z weekly 0.7 https://app.quri.ai/trials/NCT07458217/combined-cm-and-stn-stimulation-for-motor-epilepsy 2026-03-13T00:34:30.194Z weekly 0.7 https://app.quri.ai/trials/NCT07457918/long-term-follow-up-study-of-cantharidin-ycanth-vp-102-to-20 2026-03-12T00:34:43.240Z weekly 0.7 https://app.quri.ai/trials/NCT07456826/study-evaluating-the-efficacy-and-safety-of-chloroprocaine-h 2026-04-03T00:36:13.356Z weekly 0.7 https://app.quri.ai/trials/NCT07458269/efficacy-and-safety-of-kai-9531-administered-once-weekly-in- 2026-03-12T00:35:23.319Z weekly 0.7 https://app.quri.ai/trials/NCT04393285/abemaciclib-and-letrozole-to-treat-endometrial-cancer 2026-03-12T00:34:49.226Z weekly 0.7 https://app.quri.ai/trials/NCT07457190/pharmacokinetic-study-of-buagafuran-capsules-in-participants 2026-03-13T00:34:28.443Z weekly 0.7 https://app.quri.ai/trials/NCT07458542/effectiveness-and-safety-of-onureg-oral-azacitidine-in-chine 2026-03-12T00:35:05.203Z weekly 0.7 https://app.quri.ai/trials/NCT07459036/artificial-intelligence-guided-versus-manual-cbct-planning-f 2026-03-12T00:34:00.155Z weekly 0.7 https://app.quri.ai/trials/NCT07457723/gut-microbiome-and-metabolic-health-study 2026-03-12T00:33:57.770Z weekly 0.7 https://app.quri.ai/trials/NCT07456839/a-mutiple-dose-study-of-ibi3033-in-healthy-participants 2026-03-12T00:33:59.944Z weekly 0.7 https://app.quri.ai/trials/NCT07456930/real-world-evaluation-of-compl-ai-for-predicting-early-medic 2026-03-21T00:40:00.846Z weekly 0.7 https://app.quri.ai/trials/NCT07457671/tar-0520-gel-in-hand-and-foot-syndrome 2026-03-12T00:35:15.111Z weekly 0.7 https://app.quri.ai/trials/NCT06999408/efficacy-and-safety-of-targetcool-benev-exosomes-in-patients 2026-03-12T00:34:30.688Z weekly 0.7 https://app.quri.ai/trials/NCT07458243/registry-of-enroute-nps-in-conjunction-with-carotid-wallsten 2026-03-14T00:36:08.702Z weekly 0.7 https://app.quri.ai/trials/NCT07457242/probiotic-research-open-label-functional-intervention-and-lo 2026-03-12T00:34:31.933Z weekly 0.7 https://app.quri.ai/trials/NCT07456969/non-invasive-malaria-diagnostic-data-collection-in-ethiopia 2026-03-12T00:34:14.560Z weekly 0.7 https://app.quri.ai/trials/NCT07458191/apixaban-safety-and-therapy-adherence-in-patients-with-atria 2026-03-14T00:36:14.299Z weekly 0.7 https://app.quri.ai/trials/NCT07457580/real-world-study-of-patients-with-type-1-diabetes-treated-wi 2026-03-26T00:34:15.472Z weekly 0.7 https://app.quri.ai/trials/NCT07457164/a-study-investigating-the-pharmacokinetics-pharmacodynamics- 2026-03-15T00:34:12.306Z weekly 0.7 https://app.quri.ai/trials/NCT07459556/a-prospective-study-of-stapokibart-injection-in-patients-wit 2026-03-12T00:33:59.259Z weekly 0.7 https://app.quri.ai/trials/NCT07457203/study-on-the-drug-interaction-between-buagafuran-and-voricon 2026-03-12T00:34:28.994Z weekly 0.7 https://app.quri.ai/trials/NCT07459426/entecavir-resistance-associated-mutations-in-chronic-hbv-pat 2026-03-12T00:35:19.608Z weekly 0.7 https://app.quri.ai/trials/NCT07459439/feasibility-of-virtual-reality-assisted-ergometer-cycling-in 2026-03-12T00:34:16.929Z weekly 0.7 https://app.quri.ai/trials/NCT07456891/remibrutinib-open-label-roll-over-post-trial-access-protocol 2026-03-12T00:34:57.686Z weekly 0.7 https://app.quri.ai/trials/NCT07458464/a-study-to-investigate-stannous-fluoride-containing-toothpas 2026-03-12T00:34:41.180Z weekly 0.7 https://app.quri.ai/trials/NCT05719454/novel-setup-algorithm-for-cardiac-neuromodulation-therapy 2026-03-12T00:34:23.726Z weekly 0.7 https://app.quri.ai/trials/NCT07459543/a-study-to-assess-the-safety-and-tolerability-of-nivolumab-r 2026-03-26T15:36:54.442Z weekly 0.7 https://app.quri.ai/trials/NCT07457593/expanded-access-for-inhaled-isoflurane-delivered-via-the-sed 2026-03-12T00:34:48.248Z weekly 0.7 https://app.quri.ai/trials/NCT07458347/a-phase-1-dose-escalation-trial-of-kst-6051-in-participants- 2026-03-27T00:31:50.605Z weekly 0.7 https://app.quri.ai/trials/NCT07457229/phase-1-open-label-study-of-radiprodil-pharmacokinetics-safe 2026-03-12T00:34:14.758Z weekly 0.7 https://app.quri.ai/trials/NCT07459452/trial-of-jyb1904-injection-in-patients-with-perennial-allerg 2026-03-12T00:34:25.272Z weekly 0.7 https://app.quri.ai/trials/NCT07459114/tgd001-treatment-in-thrombotic-microangiopathies 2026-03-12T00:34:11.346Z weekly 0.7 https://app.quri.ai/trials/NCT07458516/longitudinal-observational-study-of-diabetic-retinopathy-pro 2026-03-14T00:36:07.946Z weekly 0.7 https://app.quri.ai/trials/BF-26-01/change-in-diurnal-intraocular-pressure-fluctuation-following 2026-03-09T03:03:42.114Z weekly 0.7 https://app.quri.ai/trials/NCT05335122/a-study-to-evaluate-the-efficacy-and-safety-of-otx-tic-travo 2026-03-09T02:55:24.064Z weekly 0.7 https://app.quri.ai/trials/NCT04503590/mims-minimally-invasive-micro-sclerostomy-with-mitomycin-c-n 2026-03-09T02:55:20.685Z weekly 0.7 https://app.quri.ai/trials/NCT04742283/sepetaprost-angel-2-trial-nct04742283-in-open-angle-glaucoma 2026-03-09T02:55:17.730Z weekly 0.7 https://app.quri.ai/trials/NCT06249152/qls-111-apteryx-trial-nct06249152-phase-ii-in-open-angle-gla 2026-03-09T02:55:16.174Z weekly 0.7 https://app.quri.ai/trials/KOMET-Z-GIL/ziftomenib-gilteritinib-in-relapsed-refractory-aml-early-pha 2026-03-08T06:04:53.659Z weekly 0.7 https://app.quri.ai/trials/FIT-001-DAR/fit-001-darlifarnib-cabozantinib-in-advanced-renal-cell-carc 2026-03-08T06:04:52.638Z weekly 0.7 https://app.quri.ai/trials/NCT05185622; NCT03863119/results-of-a-phase-ii-open-label-multiple-dose-study-of-vamo 2026-03-08T06:02:29.034Z weekly 0.7 https://app.quri.ai/trials/NCT07455474/clinical-research-study-of-the-benefits-of-breg-polar-care-w 2026-03-08T05:36:14.029Z weekly 0.7 https://app.quri.ai/trials/ULTIMATE_I_II/ultimate-i-ii-phase-3-studies-of-briumvi-ublituximab-xiiy-in 2026-03-08T05:35:55.451Z weekly 0.7 https://app.quri.ai/trials/KEYNOTE-676/pembrolizumab-mk-3475-in-combination-with-bacillus-calmette- 2026-03-08T05:19:10.297Z weekly 0.7 https://app.quri.ai/trials/FIT-001/fit-001-phase-1b-dose-expansion-of-darlifarnib-plus-cabozant 2026-03-08T05:02:23.256Z weekly 0.7 https://app.quri.ai/trials/KOMET-008/komet-008-additional-cohorts-evaluating-ziftomenib-in-combin 2026-03-08T05:02:22.823Z weekly 0.7 https://app.quri.ai/trials/KOMET-007/komet-007-phase-1-data-in-newly-diagnosed-aml-treated-with-z 2026-03-08T05:02:22.295Z weekly 0.7 https://app.quri.ai/trials/KOMET-017/komet-017-ziftomenib-registrational-program-in-newly-diagnos 2026-03-08T05:02:22.072Z weekly 0.7 https://app.quri.ai/trials/S-38210/s-38210-semaglutide-or-liraglutide-in-adults-with-type-2-dia 2026-03-09T19:25:09.029Z weekly 0.7 https://app.quri.ai/trials/NCT04605549/a-multicenter-open-label-study-to-evaluate-the-safety-tolera 2026-03-08T04:40:55.465Z weekly 0.7 https://app.quri.ai/trials/ULTIMATE_II/ultimate-ii-phase-3-study-of-briumvi-in-relapsing-multiple-s 2026-03-08T04:12:23.097Z weekly 0.7 https://app.quri.ai/trials/ULTIMATE_I/ultimate-i-phase-3-study-of-briumvi-in-relapsing-multiple-sc 2026-03-08T04:12:22.394Z weekly 0.7 https://app.quri.ai/trials/K9531-2110/weight-loss-trial-k9531-2110-glp-1-gip-dual-agonist-for-obes 2026-03-08T03:55:06.423Z weekly 0.7 https://app.quri.ai/trials/DECLARATION/invivyd-declaration-trial-evaluating-vyd2311-for-prevention- 2026-03-08T03:50:51.475Z weekly 0.7 https://app.quri.ai/trials/3298/002/safety-and-tolerability-of-a-modified-ublituximab-dosing-reg 2026-03-08T03:10:40.637Z weekly 0.7 https://app.quri.ai/trials/VAX-A1-Phase-I/vax-a1-group-a-streptococcus-phase-i-safety-and-immunogenici 2026-03-08T03:01:03.013Z weekly 0.7 https://app.quri.ai/trials/VAX-24 Phase II/vax-24-phase-ii-dose-finding-study-in-infants 2026-03-08T03:01:02.667Z weekly 0.7 https://app.quri.ai/trials/VAX-31 Infant Phase II Optimized Arm/vax-31-infant-phase-ii-study-optimized-dose-arm 2026-03-08T03:01:02.225Z weekly 0.7 https://app.quri.ai/trials/2137/005/real-world-clinical-experience-from-enable-the-first-phase-4 2026-03-08T02:54:56.916Z weekly 0.7 https://app.quri.ai/trials/NCT04364230/phase-i-ii-clinical-trial-of-cdx-1140-in-combination-with-6m 2026-03-08T02:39:34.201Z weekly 0.7 https://app.quri.ai/trials/Unknown/kandle-study-servier-kcnt1-related-developmental-and-epilept 2026-03-08T02:30:15.055Z weekly 0.7 https://app.quri.ai/trials/NCT06178588/sacituzumab-govitecan-in-previously-treated-biliary-tract-ca 2026-03-08T02:21:42.855Z weekly 0.7 https://app.quri.ai/trials/NORSE TWO/outlook-therapeutics-lytenava-norse-two-phase-3-trial-in-wet 2026-03-07T02:48:22.342Z weekly 0.7 https://app.quri.ai/trials/ENERGIZE/ENERGIZE-T/agios-mitapivat-pyrukynd-energize-and-energize-t-phase-3-tri 2026-03-07T02:48:22.192Z weekly 0.7 https://app.quri.ai/trials/TRANSCEND/rhythm-transcend-phase-3-setmelanotide-in-acquired-hypothala 2026-03-07T02:48:11.286Z weekly 0.7 https://app.quri.ai/trials/Serena-6/serena-6-camizestrant-added-to-first-line-therapy-in-esr1-mu 2026-03-07T02:13:49.733Z weekly 0.7 https://app.quri.ai/trials/CAPItello-280/capitello-280-camizestrant-in-metastatic-castration-resistan 2026-03-07T02:13:48.055Z weekly 0.7 https://app.quri.ai/trials/CAPItello-281/capitello-281-camizestrant-in-combination-with-abiraterone-i 2026-03-07T02:13:47.589Z weekly 0.7 https://app.quri.ai/trials/NCT07448428/generalized-pustular-psoriasis-registry-in-costa-rica 2026-03-12T00:33:57.353Z weekly 0.7 https://app.quri.ai/trials/NCT07448363/atopic-dermatitis-treated-with-dupilumab-and-jak-inhibitors- 2026-03-07T00:36:08.940Z weekly 0.7 https://app.quri.ai/trials/NCT07448337/psoriasis-comorbidities-at-hospital-calder-n-guardia 2026-03-07T00:36:08.757Z weekly 0.7 https://app.quri.ai/trials/NCT07448389/epidemiological-clinical-diagnostic-and-therapeutic-characte 2026-03-12T00:34:26.437Z weekly 0.7 https://app.quri.ai/trials/NCT07448402/costa-rican-registry-of-il-23-inhibitors-in-psoriatic-diseas 2026-03-12T00:34:17.168Z weekly 0.7 https://app.quri.ai/trials/NCT07451626/clinical-epidemiologic-and-therapeutic-characterization-of-p 2026-03-12T00:35:08.813Z weekly 0.7 https://app.quri.ai/trials/NCT07450755/concomitant-pfa-bsaed-pvi-plus-laac 2026-03-15T00:34:55.626Z weekly 0.7 https://app.quri.ai/trials/NCT07454096/application-of-radiomics-for-diagnosis-and-follow-up-of-card 2026-03-09T00:32:43.254Z weekly 0.7 https://app.quri.ai/trials/NCT07456046/a-phase-1-study-of-d3s-003-as-monotherapy-in-participants-wi 2026-03-20T00:36:19.385Z weekly 0.7 https://app.quri.ai/trials/NCT07453602/ph-1a-1b-single-ascending-dose-and-multiple-ascending-dose-s 2026-03-12T00:34:17.944Z weekly 0.7 https://app.quri.ai/trials/NCT07455383/a-study-to-evaluate-the-efficacy-and-safety-of-alks-2680-in- 2026-03-12T00:34:26.006Z weekly 0.7 https://app.quri.ai/trials/NCT07454863/a-mass-balance-study-of-dzd8586-in-healthy-male-participants 2026-03-09T00:32:40.044Z weekly 0.7 https://app.quri.ai/trials/NCT07453784/phase-1-study-to-evaluate-pharmacokinetics-relative-bioavail 2026-03-09T00:32:38.504Z weekly 0.7 https://app.quri.ai/trials/NCT07456371/pic1-injection-therapy-for-relapsed-refractory-b-nhl 2026-03-09T00:32:31.001Z weekly 0.7 https://app.quri.ai/trials/NCT07454720/a-randomized-double-blind-placebo-controlled-multicenter-pha 2026-03-09T00:32:29.351Z weekly 0.7 https://app.quri.ai/trials/NCT07454525/examine-impact-of-topical-application-of-active-versus-place 2026-03-09T00:32:24.862Z weekly 0.7 https://app.quri.ai/trials/NCT07453914/clinical-assessment-of-respiratory-events-for-kids-integrati 2026-03-09T00:32:23.646Z weekly 0.7 https://app.quri.ai/trials/NCT07455734/early-phase-trial-to-assess-the-safety-and-preliminary-effic 2026-04-03T00:34:11.504Z weekly 0.7 https://app.quri.ai/trials/NCT07453394/qls5132-combination-therapy-in-advanced-solid-tumors 2026-03-09T00:32:19.404Z weekly 0.7 https://app.quri.ai/trials/NCT07456033/a-study-of-efficacy-and-safety-of-depemokimab-compared-with- 2026-03-09T00:32:08.931Z weekly 0.7 https://app.quri.ai/trials/NCT07454837/phase-2b-3-study-to-evaluate-switching-to-brelovitug-for-the 2026-04-03T00:34:05.996Z weekly 0.7 https://app.quri.ai/trials/NCT07455617/study-of-abo2102-in-kras-mutated-solid-tumors 2026-03-09T00:32:06.308Z weekly 0.7 https://app.quri.ai/trials/NCT07455136/a-study-to-develop-a-blood-based-test-for-aiding-the-diagnos 2026-03-09T00:32:04.198Z weekly 0.7 https://app.quri.ai/trials/NCT07455006/safety-and-efficacy-study-of-ql0911-to-treat-immune-thromboc 2026-03-09T00:32:03.498Z weekly 0.7 https://app.quri.ai/trials/NCT07454187/to-evaluate-the-safety-of-sg2918-in-patients-with-relapsed-r 2026-03-09T00:32:01.600Z weekly 0.7 https://app.quri.ai/trials/NCT07454850/a-study-of-patient-characteristics-co-morbidities-and-treatm 2026-04-03T00:37:07.243Z weekly 0.7 https://app.quri.ai/trials/NCT07455084/a-study-to-detect-the-radioactivity-of-14c-sep-380135-in-uri 2026-03-09T00:31:55.563Z weekly 0.7 https://app.quri.ai/trials/NCT07456774/a-two-armed-real-world-study-of-ozempic-ow-semaglutide-to-ev 2026-03-09T00:31:54.748Z weekly 0.7 https://app.quri.ai/trials/NCT07455851/a-trial-to-study-if-regn17372-in-combination-with-linvoselta 2026-03-09T00:31:53.607Z weekly 0.7 https://app.quri.ai/trials/NCT07454291/a-phase-1-open-label-study-to-evaluate-pharmacokinetics-and- 2026-03-09T00:31:52.260Z weekly 0.7 https://app.quri.ai/trials/NCT05306301/ponatinib-plus-chemotherapy-in-acute-lymphoblastic-leukemia- 2026-03-09T00:31:49.883Z weekly 0.7 https://app.quri.ai/trials/NCT07455058/water-vapor-ablation-for-prostate-cancer-long-term-registry 2026-03-09T00:31:48.652Z weekly 0.7 https://app.quri.ai/trials/NCT07455045/a-phase-i-study-of-fz-ad005-in-patients-with-high-grade-glio 2026-03-09T00:31:47.212Z weekly 0.7 https://app.quri.ai/trials/NCT07455526/facilitation-to-increase-tobacco-treatment 2026-03-09T00:31:46.474Z weekly 0.7 https://app.quri.ai/trials/NCT04460963/role-of-adrenomedullin-in-leukemic-endosteal-vascular-niches 2026-03-09T00:31:42.858Z weekly 0.7 https://app.quri.ai/trials/NCT07455825/a-study-to-investigate-the-pharmacokinetics-of-different-for 2026-03-15T00:35:06.963Z weekly 0.7 https://app.quri.ai/trials/NCT07455864/lysosomal-acid-lipase-deficiency-in-risk-groups 2026-03-09T00:31:40.661Z weekly 0.7 https://app.quri.ai/trials/NCT07455812/a-study-in-germany-to-learn-about-the-value-of-fezolinetant- 2026-03-09T00:31:40.298Z weekly 0.7 https://app.quri.ai/trials/NCT07456150/personalizing-veteran-pain-care-adapting-coaching-interventi 2026-03-09T00:31:38.561Z weekly 0.7 https://app.quri.ai/trials/NCT07455578/study-of-s-4321-in-participants-with-an-autoimmune-or-immune 2026-03-09T00:31:37.810Z weekly 0.7 https://app.quri.ai/trials/NCT07453693/an-efficacy-study-of-a-dietary-supplement-drink-mix-for-urin 2026-03-09T00:31:36.754Z weekly 0.7 https://app.quri.ai/trials/NCT07454889/a-real-world-study-of-patients-with-hidradenitis-suppurativa 2026-03-09T00:31:28.661Z weekly 0.7 https://app.quri.ai/trials/NCT07453836/research-on-yts109-cell-in-patients-with-recurrent-refractor 2026-03-09T00:31:26.183Z weekly 0.7 https://app.quri.ai/trials/NCT07454915/pvx4-for-the-treatment-of-human-papilloma-virus-hpv-16-cervi 2026-03-12T00:34:41.406Z weekly 0.7 https://app.quri.ai/trials/NCT07454122/cd5car-nk-cells-for-refractory-invasive-mold-disease 2026-03-09T00:31:24.181Z weekly 0.7 https://app.quri.ai/trials/NCT07456059/a-study-to-evaluate-edg-7500-in-caucasian-and-japanese-adult 2026-03-09T00:31:23.217Z weekly 0.7 https://app.quri.ai/trials/NCT07453446/clinical-study-of-u29-injection-cd30-cart-in-patients-with-c 2026-03-09T00:31:22.031Z weekly 0.7 https://app.quri.ai/trials/NCT07453797/a-prospective-study-assessing-activsight-imaging-for-intraop 2026-03-09T00:31:21.834Z weekly 0.7 https://app.quri.ai/trials/NCT07456397/development-of-an-ai-platform-for-the-analysis-of-sperm-and- 2026-03-09T00:31:20.851Z weekly 0.7 https://app.quri.ai/trials/NCT07455747/real-world-treatment-of-extracranial-carotid-artery-disease- 2026-03-09T00:31:19.916Z weekly 0.7 https://app.quri.ai/trials/NCT07453888/efficacy-and-safety-of-intranasal-cenegermin-in-adult-partic 2026-03-09T00:31:13.239Z weekly 0.7 https://app.quri.ai/trials/NCT07455240/a-study-to-learn-about-how-the-body-processes-the-study-medi 2026-03-26T00:34:00.558Z weekly 0.7 https://app.quri.ai/trials/NCT07453823/the-effect-of-a-synbiotic-on-intestinal-barrier-function-and 2026-03-09T00:31:11.174Z weekly 0.7 https://app.quri.ai/trials/NCT07456696/an-evaluation-of-the-safety-and-efficacy-of-tsnd-201-for-the 2026-03-15T00:33:55.821Z weekly 0.7 https://app.quri.ai/trials/NCT07454356/knee-flexionater-to-avoid-motion-restoring-surgery 2026-03-09T00:31:09.676Z weekly 0.7 https://app.quri.ai/trials/NCT07454642/ava6103-in-subjects-with-locally-advanced-or-metastatic-sele 2026-03-21T00:39:00.305Z weekly 0.7 https://app.quri.ai/trials/NCT07454603/a-prospective-clinical-trial-evaluating-prostest-a-blood-bas 2026-03-09T00:31:08.211Z weekly 0.7 https://app.quri.ai/trials/NCT07454980/pivotal-trial-to-evaluate-transvenous-tricuspid-valve-replac 2026-03-09T00:31:04.922Z weekly 0.7 https://app.quri.ai/trials/NCT02592941/deflazacort-expanded-access-program-for-children-adolescents 2026-03-06T06:30:14.632Z weekly 0.7 https://app.quri.ai/trials/PH FDC SC Home Administration/provide-at-home-subcutaneous-administration-of-pertuzumab-an 2026-03-06T06:25:04.411Z weekly 0.7 https://app.quri.ai/trials/ABBV-400-cohort-study/adverse-events-and-change-in-disease-activity-in-adult-parti 2026-03-06T06:24:46.285Z weekly 0.7 https://app.quri.ai/trials/NCT04673383/dmt-fumarate-spl026-in-adults-with-major-depressive-disorder 2026-03-06T06:22:56.250Z weekly 0.7 https://app.quri.ai/trials/TV56278-ONC-10203/tv56278-onc-10203-tev-56278-in-advanced-solid-tumors 2026-03-06T05:54:59.198Z weekly 0.7 https://app.quri.ai/trials/KT-US-679-0788/kt-us-679-0788-phase-3-protocol-comparing-anitocabtagene-aut 2026-03-06T05:54:58.343Z weekly 0.7 https://app.quri.ai/trials/BNT113-01/bnt113-01-study-of-bnt113-in-combination-with-pembrolizumab- 2026-03-06T05:54:46.889Z weekly 0.7 https://app.quri.ai/trials/NCT01767311/lecanemab-in-early-alzheimer-s-disease-phase-2b-dose-finding 2026-03-06T05:51:28.503Z weekly 0.7 https://app.quri.ai/trials/ADAPT OCULUS/argenx-announces-phase-3-adapt-oculus-results-for-vyvgart-in 2026-03-06T05:37:09.621Z weekly 0.7 https://app.quri.ai/trials/NCT01868997; NCT03298867; RCT2031210453/assessment-of-quality-of-life-qol-by-baseline-factors-among- 2026-03-06T05:26:50.145Z weekly 0.7 https://app.quri.ai/trials/NCT04876534/tocilizumab-in-thyroid-eye-disease-ted-randomized-trial-vs-m 2026-03-06T05:26:41.753Z weekly 0.7 https://app.quri.ai/trials/MK-3475-03B/KEYMAKER-U03/a-study-of-immune-and-targeted-combination-therapies-in-part 2026-03-06T05:23:03.623Z weekly 0.7 https://app.quri.ai/trials/VRDN-008/vrdn-008-ind-cleared-and-phase-1-clinical-trial-initiated-in 2026-03-06T05:08:50.603Z weekly 0.7 https://app.quri.ai/trials/VRDN-006/vrdn-006-phase-1-proof-of-concept-fcrn-inhibitor-in-healthy- 2026-03-06T05:08:50.152Z weekly 0.7 https://app.quri.ai/trials/THRIVE/thrive-phase-3-pivotal-trial-evaluating-veligrotug-for-the-t 2026-03-06T05:08:48.108Z weekly 0.7 https://app.quri.ai/trials/ADAPT_OCULUS/adapt-oculus-phase-3-study-of-vyvgart-in-ocular-myasthenia-g 2026-03-06T04:55:10.857Z weekly 0.7 https://app.quri.ai/trials/NCT06965309/efficacy-and-safety-of-hn2301-in-refractory-myasthenia-gravi 2026-03-06T04:53:57.998Z weekly 0.7 https://app.quri.ai/trials/NCT06463587/a-phase-3-randomized-double-blind-placebo-controlled-3-arm-3 2026-03-06T04:40:52.726Z weekly 0.7 https://app.quri.ai/trials/VK0214-Phase1b-AMN/vk0214-phase-1b-trial-in-x-ald-amn 2026-03-06T03:47:37.542Z weekly 0.7 https://app.quri.ai/trials/ATMOSPHERE; ASCENT; AAVIATE/abbv-rgx-314-for-neovascular-amd-atmosphere-ascent-aaviate 2026-03-06T03:44:45.169Z weekly 0.7 https://app.quri.ai/trials/ARTEMIS/advm-022-artemis-for-neovascular-amd 2026-03-06T03:44:43.745Z weekly 0.7 https://app.quri.ai/trials/4FRONT-1; 4FRONT-2/4d-150-4front-1-and-4front-2-for-neovascular-age-related-mac 2026-03-06T03:44:41.545Z weekly 0.7 https://app.quri.ai/trials/NCT06375239/a-clinical-study-evaluating-the-safety-tolerability-and-effi 2026-03-06T03:39:11.306Z weekly 0.7 https://app.quri.ai/trials/LYNX-3/opus-genetics-doses-first-patient-in-phase-3-lynx-3-trial-ev 2026-03-06T02:59:22.524Z weekly 0.7 https://app.quri.ai/trials/NCT07449988/modified-platform-trial-assessing-multiple-umbilical-cord-ba 2026-03-07T00:36:24.128Z weekly 0.7 https://app.quri.ai/trials/NCT07450183/perioperative-cemiplimab-for-resectable-non-small-cell-lung- 2026-03-07T00:34:47.881Z weekly 0.7 https://app.quri.ai/trials/NCT07449234/a-study-of-guselkumab-after-switching-from-ustekinumab-in-pa 2026-03-16T00:32:30.300Z weekly 0.7 https://app.quri.ai/trials/NCT07448155/a-study-to-evaluate-the-pharmacokinetics-safety-and-tolerabi 2026-03-14T00:37:13.578Z weekly 0.7 https://app.quri.ai/trials/NCT03347318/target-therapies-resistance-molecular-profiling-in-patients- 2026-03-22T00:33:32.254Z weekly 0.7 https://app.quri.ai/trials/NCT07450222/implementation-of-effective-hypertension-management-approach 2026-03-20T00:36:08.660Z weekly 0.7 https://app.quri.ai/trials/NCT07448584/lok-suture-anchors-safety-performance-trial 2026-03-07T00:36:13.632Z weekly 0.7 https://app.quri.ai/trials/NCT07452679/effectiveness-of-osteopathy-as-an-adjunct-to-optometric-visi 2026-03-28T00:34:59.841Z weekly 0.7 https://app.quri.ai/trials/NCT05247684/ak112-neoadjuvant-adjuvant-treatment-for-resectable-nsclc 2026-03-08T00:32:47.825Z weekly 0.7 https://app.quri.ai/trials/NCT07453004/a-study-to-evaluate-the-efficacy-safety-tolerability-pharmac 2026-03-08T00:33:20.634Z weekly 0.7 https://app.quri.ai/trials/NCT07450859/a-study-of-bt5528-in-patients-with-metastatic-pancreatic-duc 2026-03-08T00:33:53.849Z weekly 0.7 https://app.quri.ai/trials/NCT07451665/efficacy-and-safety-of-vunakizumab-and-ivarmacitinib-in-the- 2026-03-08T00:33:43.868Z weekly 0.7 https://app.quri.ai/trials/NCT07363473/journey-lvad-journey-left-ventricular-assist-device 2026-03-08T00:33:46.757Z weekly 0.7 https://app.quri.ai/trials/NCT07453069/effect-of-fb301-on-vaginal-bacterial-profile-in-women-with-a 2026-03-08T00:33:46.015Z weekly 0.7 https://app.quri.ai/trials/NCT07452692/a-study-to-assess-the-skin-irritation-and-sensitization-of-s 2026-03-09T00:31:04.706Z weekly 0.7 https://app.quri.ai/trials/NCT07452549/safety-and-effectiveness-of-tetranite-bone-adhesive-for-cran 2026-03-08T00:32:38.100Z weekly 0.7 https://app.quri.ai/trials/NCT07453082/a-prospective-study-to-evaluate-mirna371-and-outcomes-in-pat 2026-03-08T00:33:06.083Z weekly 0.7 https://app.quri.ai/trials/NCT07450664/observational-study-of-vykat-xr-in-patients-with-prader-will 2026-03-08T00:32:37.321Z weekly 0.7 https://app.quri.ai/trials/NCT07452744/efficacy-and-safety-of-picroliv-in-patients-with-non-alcohol 2026-03-15T00:33:31.077Z weekly 0.7 https://app.quri.ai/trials/NCT07450820/optimise-ckd-study-dapagliflozin-effectiveness-in-ckd 2026-03-30T00:32:25.706Z weekly 0.7 https://app.quri.ai/trials/NCT07451002/a-study-to-assess-adherence-to-apalutamide-in-metastatic-hor 2026-03-08T00:33:17.273Z weekly 0.7 https://app.quri.ai/trials/NCT07451808/male-pelvic-floor-muscle-rehabilitation-exercises 2026-03-26T00:33:48.260Z weekly 0.7 https://app.quri.ai/trials/NCT07450976/a-study-of-shr-a1904-in-previous-systemic-treatment-failed-b 2026-04-03T00:36:42.852Z weekly 0.7 https://app.quri.ai/trials/NCT07452822/safety-and-efficacy-study-of-human-umbilical-cord-mesenchyma 2026-03-08T00:32:40.908Z weekly 0.7 https://app.quri.ai/trials/NCT07451119/making-meals-with-pulses 2026-03-28T00:34:49.404Z weekly 0.7 https://app.quri.ai/trials/NCT07452523/tolerance-palatability-and-acceptability-evaluation-of-an-or 2026-03-08T00:33:36.153Z weekly 0.7 https://app.quri.ai/trials/NCT07453095/study-with-glofitamab-in-patients-with-mcl-and-inadequate-re 2026-03-08T00:33:08.696Z weekly 0.7 https://app.quri.ai/trials/NCT07453173/onco-ret-supervised-resistance-training-during-total-neoadju 2026-03-08T00:33:17.868Z weekly 0.7 https://app.quri.ai/trials/NCT02285868/ati-evidence-based-guide-investigating-clinical-services 2026-03-08T00:32:38.712Z weekly 0.7 https://app.quri.ai/trials/NCT07452198/a-study-of-gr1803-injection-versus-daratumumab-pomalidomide- 2026-03-28T00:35:07.849Z weekly 0.7 https://app.quri.ai/trials/NCT07450911/a-clinical-study-evaluating-the-replacement-of-the-native-mi 2026-03-08T00:33:10.823Z weekly 0.7 https://app.quri.ai/trials/NCT06400004/lumason-infusion-vs-bolus-administrations 2026-03-08T00:32:43.431Z weekly 0.7 https://app.quri.ai/trials/NCT05568966/collection-of-blood-samples-for-new-diagnostic-devices-2 2026-03-08T00:33:07.421Z weekly 0.7 https://app.quri.ai/trials/NCT07452224/ilkn421h-plus-pembrolizumab-in-advanced-non-small-cell-lung- 2026-03-15T00:34:48.157Z weekly 0.7 https://app.quri.ai/trials/NCT07452458/temporally-modulated-pulsed-radiation-therapy-versus-standar 2026-03-08T00:32:56.429Z weekly 0.7 https://app.quri.ai/trials/P180014/post-approval-study-for-womed-leaf-resorbable-adhesion-barri 2026-03-05T06:53:46.509Z weekly 0.7 https://app.quri.ai/trials/P180001/viabahn-fortegra-venous-stent-post-approval-study 2026-03-05T06:53:45.914Z weekly 0.7 https://app.quri.ai/trials/P990040/trufill-n-bca-liquid-embolic-system-pas 2026-03-05T06:53:45.563Z weekly 0.7 https://app.quri.ai/trials/BREEZE Study - PMCF/the-breeze-study-pmcf-zenflow-spring-implant-and-delivery-sy 2026-03-05T06:53:41.370Z weekly 0.7 https://app.quri.ai/trials/Safety and Performance PAS/safety-and-performance-pas-of-setpoint-system 2026-03-05T06:53:41.257Z weekly 0.7 https://app.quri.ai/trials/EndoForce Post-Approval Study/endoforce-post-approval-study-endoforce-connector-for-endova 2026-03-05T06:53:40.676Z weekly 0.7 https://app.quri.ai/trials/P130021/omniasecure-mri-surescan-lead-model-3930m-post-approval-stud 2026-03-05T06:53:37.993Z weekly 0.7 https://app.quri.ai/trials/P250023/allurion-gastric-balloon-post-approval-study 2026-03-05T06:53:30.063Z weekly 0.7 https://app.quri.ai/trials/NCT05139017; NCT05144841; NCT05458297; NCT05406401; NCT06717347/zilovertamab-vedotin-in-hematological-malignancies-waveline- 2026-03-05T06:33:53.400Z weekly 0.7 https://app.quri.ai/trials/NCT04811092; NCT04945460; NCT05587712; NCT06664801/sotatercept-trials-for-pulmonary-vascular-diseases-hyperion- 2026-03-05T06:33:50.575Z weekly 0.7 https://app.quri.ai/trials/NCT04586231; NCT05239728; NCT06428396/litespark-011-litesp-ark-trials-belzutifan-in-previously-unt 2026-03-05T06:33:50.072Z weekly 0.7 https://app.quri.ai/trials/NCT06571045; NCT06957080/mk-3000-in-diabetic-macular-edema-brunello-nct06571045-barol 2026-03-05T06:33:48.784Z weekly 0.7 https://app.quri.ai/trials/NCT04380636; NCT03976362; NCT03976323; NCT04624204/lynparza-olaparib-in-non-small-cell-and-small-cell-lung-canc 2026-03-05T06:33:46.055Z weekly 0.7 https://app.quri.ai/trials/MK-8591A-051; NCT05631093; MK-8591A-052; NCT05630755; MK-8591A-053; NCT05705349; MK-8591A-054; NCT05766501; NCT04944992; NCT06465186/doravirine-islatravir-mk-8591a-for-hiv-1-infection-merck-pip 2026-03-05T06:33:41.207Z weekly 0.7 https://app.quri.ai/trials/KANDLELIT-012; NCT06997497; KANDLELIT-004; NCT06345729; KANDLELIT-007; NCT07190248; KANDLELIT-014; NCT07209111/calderasib-mk-1084-in-colorectal-cancer-nsclc-and-solid-tumo 2026-03-05T06:33:38.697Z weekly 0.7 https://app.quri.ai/trials/NCT06079879; NCT06456346; NCT06351631/bomedemstat-mk-3543-in-myeloproliferative-disorders-merck-pi 2026-03-05T06:33:37.198Z weekly 0.7 https://app.quri.ai/trials/NCT03846193/gt005-complement-factor-i-for-geographic-atrophy-in-amd 2026-03-05T05:45:46.210Z weekly 0.7 https://app.quri.ai/trials/NCT03066258/rgx-314-for-neovascular-amd-phase-i-iia-dose-escalation-stud 2026-03-05T05:45:45.055Z weekly 0.7